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The effects of maternal overnutrition in mares has yet to be fully elucidated; 
therefore, the objectives of these studies were to determine the effects of maternal 
overnutrition on neonatal foals at cellular and molecular levels to describe fetal origins 
of adult disease in the horse.  To test these objectives, 16 Quarter Horse mares were used 
in a completely randomized design and separated by BW, BCS and expected foaling 
date into one of two dietary treatments consisting of a control (CON; n=8) where diets 
were formulated to meet dietary requirements during late gestation or overfed (HIGH; 
n=8) where mares received 40% above CON.  Results indicate reduced insulin 
sensitivity in HIGH mares prior to parturition (P£0.02) but was not observed in foals 
immediately postpartum.  Pancreas of HIGH foals had greater number and size of 
endocrine islets determined by immunohistochemical staining (P<0.01).  Relative 
intensity of immunofluorescent immunoreactive insulin, glucagon and somatostatin 
within individual islets were not different, however.   
Skeletal muscle of HIGH foals expressed larger individual fibers (P£0.09) and a 
shift towards type I slow twitch fibers (P£0.04).  Changes in expression of genes 
involved in insulin-stimulated glucose uptake were also observed.  Specifically, reduced 
expression of glucose transporter 4 and increased expression of insulin receptor isoform 
B and insulin-like growth factor 1 receptor.  Furthermore, key proteins involved in 




of extracellular signal-regulated protein kinase 1/2 (ERK1/2) and c-Jun N-terminal 
kinase (JNK).   
Spleen mass was larger in HIGH foals compared to CON (P=0.04), which also 
resulted in an increase in RBC storage (P<0.01).  Lymphocyte localization was not 
different between dietary treatments; therefore, differences may be with innate immune 
cells.  Collectively, these data are the first to describe the influence of maternal 
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Suboptimal conditions during critical periods of fetal development may lead to 
alterations in offspring phenotype.  This is referred to as developmental programming 
and can be influenced by many environmental factors, such as maternal nutrition, which 
is known to play a major role.  A prominent example of that is the Dutch Hunger Winter 
during World War II where Germany placed sanctions on the Netherlands, limiting the 
food supply to the Dutch people.  Children born to women pregnant during the winter 
1944-1945 experienced a high occurrence of high blood pressure, cardiovascular 
disease, obesity, and diabetes as adults (Schulz, 2010).  More recent evidence has 
determined the effects to be multi-generational (Veenendaal et al., 2013).  As such, the 
impact of maternal undernutrition has been extensively studied in many species and has 
been shown to cause intrauterine growth retardation and abnormalities in fetal 
metabolism that persist into adulthood.  This led to the investigation into fetal origins of 
adult disease.   
Although undernutrition is an excellent model for developmental programming 
in other livestock species, it may not be as applicable with regard to horses.  Rather, an 
overfed model may be more applicable to assess the influence of maternal nutrition on 
health and performance of the dam and its progeny.  This is because many performance 




performance and fetal growth.  Specifically, in 2011, the prevalence of obesity in horses 
was estimated at approximately 50% of the population (Stephenson et al., 2011).  The 
incidence of obesity has been linked to increases in metabolic disorders such as insulin 
resistance, laminitis, and equine metabolic syndrome, which limit the potential of the 
equine athlete (Rossdale and Ousey, 2002).  To date, the effects of maternal 
overnutrition during pregnancy on the offspring have yet to be fully elucidated.  Studies 
performed using rat, ovine, and recently equine models have linked overnutrition in the 
dam to potentially lasting effects on metabolism in offspring (Fowden and Hill 2001; 
Limesand et al., 2007; Long et al., 2014; Sheen et al., 2018).  Research in our lab has 
begun to identify some of these effects in mares and foals and will be described in 
further detail in this review (Winsco et al., 2013).   
Maternal under- and over-nutrition have influenced glucose metabolism, 
pancreatic endocrine function, and skeletal muscle response to insulin, adipose tissue 
metabolism, and alterations in development of many other organ systems.  Related to 
adult-onset metabolic disease, modifications to glucose dynamics and insulin sensitivity 
in neonates suggest predisposition to adult disease.  In humans, the rate of obesity in 
adult populations has been associated with an increase in obesity rate in children and an 
increase in type 2 diabetes diagnoses in children and young adults over the last 18 years 
(Skinner et al., 2018).  Research in ovine, bovine, and murine models have documented 
modifications to glucose and insulin dynamics in response to changes in maternal plane 
of nutrition in all stages of pregnancy (Limesand et al., 2007; Long et al., 2010; Wilson 




Development and Function of Organs and Tissues 
 Organ systems develop at different times of gestation, beginning with the central 
nervous system and ending with maturation of the lungs and respiratory system 
immediately prior to parturition.  Development of organs and functional cells within 
organs are subject to environmental influences to prepare the fetus for life within that 
environment.  In order to understand changes in organ/tissue development in response to 
maternal plane of nutrition, normal development of organs and systems must be 
understood.  The pancreas and skeletal muscle are the primary regulators of glucose 
concentrations, storage, and utilization.  Furthermore, the spleen is especially sensitive to 
maternal plane of nutrition related to size and mass; therefore, this review will focus on 
the pancreas, skeletal muscle, and spleen development and subsequent influence by 
maternal plane of nutrition.   
Pancreas 
Little is known about pancreatic development specific to the horse; however 
genetic control and expression of transcription factors is likely similar to what has been 
observed in mice and humans, with differences primarily related to time of gestation 
(Fowden and Hill, 2001).  The pancreas develops in two main phases, primary and 
secondary, where the pancreatic buds are developed in the primary phase followed by 
cellular differentiation and activation in the secondary phase.  Initiation of pancreatic 
bud development occurs early in first trimester in conjunction with gastrointestinal 
development.  Cellular differentiation in humans occurs in the second half of the first 




The pancreas is derived from the embryonic foregut endoderm and begins with 
the development of the dorsal bud upon signals from activin, fibroblastic growth factor, 
and vascular endothelial growth factor (Bastidas-Ponce et al., 2017).  Ultimately, the 
dorsal and ventral buds will fuse to form the adult pancreas.  Expression of pancreatic 
and duodenal homeobox 1 (Pdx1) and SRY-Box 9 (SOX9) are the primary transcription 
factors responsible for the stimulation of pancreatic induction with SOX9 providing a 
positive-feedback mechanism to prevent cellular default to liver fate (Bastidas-Ponce et 
al., 2017).  Once pancreatic induction has begun, multipotent progenitor cells (MPCs) 
form under regulation of Pdx1 and pancreas-specific transcription factor 1a (Ptf1a; 
Burlison et al., 2008).  The dorsal bud of the pancreas sits in close proximity to the 
notochord and aorta; therefore, signaling molecules to induce pancreatic bud formation 
primarily via suppression of sonic hedgehog (SHH) and inclusion of activin and 
fibroblastic growth factor (FGF; Bastidas-Ponce et al., 2017).  Expression of FGFs, 
Pdx1, and Ptf1a ultimately prevent the developing pancreas from diverting towards a 
liver fate in a feed-forward loop (Seymour et al., 2012).  Signaling induction of ventral 
pancreas is still unclear; however, it is known to be derived from the posterior segment 
of the ventral foregut endoderm (Bastidas-Ponce et al., 2017). The dorsal bud gives rise 
to the head, neck, body and tail regions of the pancreas where the ventral bud contributes 
solely to the posterior portion of the head of the pancreas (Uchida et al., 1999).   
The specific formation of endocrine cells occurs during the secondary phase of 
pancreatic development.  Endocrine cells are derived from MPCs in the bipotent trunk 




neurogenin 3 (Ngn3; Gradwohl et al., 2000).  In mice, the lack of Ngn3 results in 
pancreatic development with no endocrine cells resulting in death shortly after birth 
(Gradwohl et al., 2000).  Once committed to an endocrine cell fate, different 
transcription factors regulate cell specification collectively controlled by Ngn3.  Arx and 
Pax4 are dually expressed in endocrine progenitor cells; however, a shift signals 
specification with high Arx, low Pax4 differentiating a-cells, and low Arx, high Pax4 
differentiating b- and d-cells (Bastidas-Ponce et al. 2017).  
Once endocrine cells of the pancreas are mature, the endocrine pancreas 
functions to regulate fetal blood glucose levels and maintain glucose homeostasis similar 
to that of a mature animal (Fowden and Hill, 2001).  The timing of endocrine maturation 
varies and has yet to be determined in the horse.  In other species, however, this has been 
investigated with rats reaching endocrine maturation and secreting insulin into fetal 
plasma at 18 d gestation (term ~21-24 d), sheep at 60 d gestation (term ~147 d), and 
humans at 84 d gestation (term ~280 d; Fowden and Hill, 2001).  Maternal glucose is 
shunted towards the fetus, increasing fetal blood glucose concentrations.  Similar to 
mature animals, the pancreas responds to elevated blood glucose through the transport of 
glucose through glucose transporter 2 (GLUT2) on b-cell membranes.  On the other 
hand, when glucose concentrations are low, glucagon is released from pancreatic a-cells, 
also located within the islets of Langerhans.   
The central dogma of glucose-stimulated insulin secretion surrounds the 
influence of glycolysis paired with ATP production and cellular depolarization (Figure 




glucose-6-phosphate (G6P) in the first step of glycolysis for ATP production.  This first 
step prevents the return of glucose to circulation and begins the primary sensory 
mechanism for pancreatic b-cells (Wilson et al., 2017).  The metabolism of pyruvate, 
formed during the last step of glycolysis, enters the mitochondria, generating ATP 
through the citric acid cycle (TCA) and electron transport chain (Komatsu et al., 2013).  
The sudden increase in ATP in pancreatic b-cells ultimately stimulates the release of 
insulin via exocytosis.  As a result, ATP-sensitive K+ channels close leading to 
membrane depolarization, subsequent Ca2+ influx, and insulin exocytosis (Komatsu et 
al., 2013).  Once in circulation, insulin reacts with the insulin receptor on insulin-




Figure I.1 Regulation of glucose-stimulated insulin secretion from pancreatic b-cells 






When glucose concentrations in circulation are low, insulin secretion from b-
cells is suppressed and a-cells begin secreting glucagon to stimulate the liver to increase 
gluconeogenesis and glycogenolysis.  The specific signals for a-cell stimulation is 
debated; however, it is suggested that multiple paracrine signals stimulate and/or inhibit 
the secretion of glucagon to promote glucose homeostasis (Figure I.2 and I.3; Briani et 
al., 2018).  When glucose is high in circulation, insulin is released to stimulate glucose 
uptake by peripheral tissues, which lowers Ca2+ concentration in a-cells, reducing 
glucagon release.  Additionally, somatostatin is released in a pulsatile manner 
corresponding with insulin and gamma-aminobutyric acid (GABA) release from b-cells.  
Together, GABA and somatostatin express an inhibitory effect on a-cells to reduce 
glucagon secretion.  Figure I.4 expresses the pulsatile manner in which insulin and 
somatostatin are secreted in conjunction and the opposing release of glucagon when 




Figure I.2 Paracrine interaction among endocrine cells of the pancreatic islets of 





Figure I.3 Inhibition of glucagon via paracrine signaling between b- d- and a-cells 






Figure I.4 Effect of increasing insulin on somatostatin and glucagon release from d-cells 





Secondary stimulation of insulin release occurs via post-prandial secretion of 
incretins from enteroendocrine K/L cells including, glucose-dependent insulinotropic 
polypeptide (GIP) and glucagon-like peptide-1 (GLP-1; Nauck and Meier, 2018).  When 
released from enteroendocrine cells, incretins bind to their respective receptors on 
pancreatic b-cells, increase cAMP and Ca2+ thereby stimulating the release of insulin 
(Kim and Egan, 2008).  It is suggested that incretins are responsible for as much as 50% 
of b-cell stimulation (Nauck and Meier, 2018).  Determination of insulin sensitivity is 
determined using either frequent sampling i.v. glucose tolerance tests (FSIGTT) or an 
oral glucose sensitivity test.  Using FSIGTT removes the influence of incretins on 
insulin stimulation and allows for independent determination of glucose-stimulated 
insulin release.  Oral glucose tolerance tests include incretin response, but exact 
absorption of glucose from the digestive tract is uncertain.  Both methods, along with the 
hyperinsulin euglycemic clamp, are accepted means of determining insulin sensitivity 
and diagnosing insulin resistance or type 2 diabetes; however, it is important to 
determine which method is most reliable to test the desired hypothesis.    
Skeletal Muscle 
Very little research has been performed in the area of prenatal development of 
equine skeletal muscle.  Much of the research has focused on effects of training on 
skeletal muscle fibers and adaptation; however, it has yet to be determined whether 
prenatal programming may be limiting the athletic potential of young horses as they 
enter training.  Other livestock species are well ahead in investigations of fetal skeletal 




which may not be appropriate but provides important information and a basis of 
understanding.   
Similar to pancreatic development, skeletal muscle development occurs in 
primary and secondary phases.  Skeletal muscle originates from somites in the 
embryonic, paraxial mesoderm (Yan et al., 2013; Nesvadbova and Borilova, 2018).  The 
primary phase of development occurs during the embryonic stage where skeletal muscle 
fibers, adipocytes, and chondrocytes derive from the same mesenchymal cell population 
and may be considered competitive processes (Yan et al., 2013).  Myoblasts, cells 
specifically committed to skeletal muscle fate, derive from myotomes with limb muscles 
originating from the hypaxial myotome (Yokoyama and Asahara, 2011).  Commitment 
involves activation to myogenic progenitor cells via Wingless and Int (Wnt) signaling 
with expression of Pax3, Pax7, and myogenic regulatory factors (MRF; Bailey et al., 
2001).  Following specification to myoblast fate, cells increase in number and fuse to 
form multinucleated, immature myotubes.  The process by which this fusion of 
myoblasts occurs is not fully understood but signals the end of the embryonic 
development phase or primary skeletal muscle development.   
Secondary myogenesis occurs during the fetal stage of development where the 
majority of mature muscle fibers differentiate.  The number of skeletal muscle fibers 
formed during secondary myogenesis set the stage for skeletal muscle fiber number in 
postnatal life and is dependent upon the number of myogenic progenitor cells 
differentiated during embryonic development.  Furthermore, differentiation during 




maternal plane of nutrition.  While skeletal muscle fiber number is fixed, skeletal muscle 
fiber type and size are programmed during secondary skeletal muscle development.   
Skeletal muscle fiber types are classified based on fiber metabolism.  Type I 
skeletal muscle fibers are slow twitch, oxidative fibers, meaning they are slow to react 
and similarly fatigue, and have a large volume of mitochondria for oxidative metabolism 
of energy substrates.  Type II skeletal muscle fibers are fast-twitch fibers, which are 
quick to contract, but are also comparatively quick to fatigue.  Type II fibers can be 
further classified as type IIa and type IIx.  Type IIa fibers are fast-twitch oxidative fibers 
where they are similar to type I in their oxidative capacity; however, are quicker to 
contract.  Type IIx fibers, however, are fast-twitch glycolytic with the same capacity for 
quick contractility, but with fewer mitochondria for limited oxidative capacity.  In the 
horse, type I skeletal muscle fibers are the least abundant followed by type IIx with most 
abundant being fast-twitch oxidative type IIa fibers.   
Energy metabolism is slightly different by skeletal muscle fiber type; however, 
all skeletal muscle fibers are responsive to insulin stimulation for glucose uptake under 
normal metabolic conditions.  Upon the release of insulin by pancreatic b-cells described 
in the previous section, insulin reacts with insulin-specific receptors on the surface of 
skeletal muscle plasma membrane.  Upon binding to the receptor, tyrosine kinase is 
phosphorylated on the intracellular portion of the receptor stimulating downstream 
activation of key signaling pathways (Figure I.5; Shepherd and Kahn, 1999).  
Phosphoinositide-3 kinase (PI3K) phosphorylation is the rate-limiting step in stimulating 




activated by phosphoinositide-dependent kinase 1 ultimately resulting in the 
translocation of glucose transporter 4 (GLUT4) from an intracellular vesicle to an active 
membranous transporter (Alessi et al., 1997).  Once intracellular, glucose may be 
metabolized for adenosine triphosphate (ATP) production or stored for later use as 





Figure I.5 Insulin-stimulated glucose uptake in skeletal muscle of healthy individuals 





Insulin bound to its receptor on skeletal muscle also influences other metabolic 
pathways involved in cell proliferation resulting in a signaling cascade with extracellular 
signal-regulated kinase (ERK) phosphorylation to increase transcription thereby 
promoting cell proliferation through increased protein synthesis (Saltiel and Kahn, 2001; 
van Ginneken et al., 2006).  Furthermore, inflammatory cytokines associated with 
increased adiposity including tumor necrosis factor-a (TNFa) and free fatty acids 
(FFAs) activate another intracellular signaling cascade in the c-Jun amino-terminal 
kinase (JNK) pathway interfering with communication by insulin to stimulate GLUT4 
translocation (Guo et al., 2014; Hirosumi et al., 2002).  
Insulin-dependent glucose uptake is similar across skeletal muscle fiber types; 
however, the utilization of glucose or stored glycogen differs under various exercise 
conditions.  Briefly, when ATP levels plummet, glycogenolysis and glycolysis are 
stimulated in-party by glucagon released from pancreatic a-cells.  Type I and type IIa 
skeletal muscle fibers utilize glucose in the presence of oxygen through glycolysis where 
resulting pyruvate enters the TCA cycle.  Products from the TCA cycle including 
nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotide 
phosphate (NADPH) enter the electron transport chain within mitochondria to produce 
the greatest number of ATP molecules.  Unfortunately, this process may only occur 
under oxidative conditions or aerobic exercise.  Type IIx skeletal muscle fibers lack 
significant mitochondria; therefore, they lack the ability to oxidize glucose via the TCA 
cycle or electron transport chains (Zierath and Hawley, 2004).  As such, type IIx fibers 




production, and increased rate of skeletal muscle fatigue (Zierath and Hawley, 2004).  
Although they fatigue quicker and produce lesser ATP per glucose molecule compared 
to type I and type IIa fibers, type IIx skeletal muscle fibers are imperative for quick 
contractility during anaerobic exercise.   
Spleen 
 Fetal development of the spleen is not well understood.  Much of the work 
investigating splenic development focuses on immune and lymphatic development or 
erythropoietic development, independently.  The bulk of data compiled is in humans and 
rats with very little information in livestock species.  There is currently no information 
on splenic development in equine species.  The differences between splenic development 
in humans and rats is vast in relation to timing; however, order of events appear to be 
similar and therefore may be able to be applicable to livestock species.   
 The spleen is the largest organ of the lymphatic system serving two main 
functions: to filter and replace erythrocytes in circulation, and to store white blood cells 
to mount an immune response in the presence of a foreign invasion.  It is made up of two 
main histological regions; the red and white pulp.  Red pulp is predominantly 
responsible for filtration of erythrocytes while white pulp is responsible for immune cell 
storage and immune response.  Description of development of the spleen is generally 
divided into the development of immune function and development of red pulp and 
hematopoiesis.   
 The spleen develops in the dorsal mesogastrium of the mesoderm in a similar 




in the early stage of development during spleen structure establishment in order to 
prepare the spleen to take over hematopoiesis from the placenta until bone marrow is 
mature (Endo et al., 2015; Vellguth et al., 1985) Hematopoietic cells are detectable as 
early as week 7 of gestation in humans with establishment of characteristic lobules and 
functional vasculature soon to follow (Endo et al., 2015; Vellguth et al., 1985).  The 
white pulp and immune functions of the spleen begin to develop simultaneously with the 
establishment of lobules and functional vasculature (Vellguth et al., 1985).   
In humans, the white pulp develops around 15 weeks of gestation with clusters of 
intermediate-sized immature lymphocytes collecting around the developing arterioles 
(Timens et al., 1987).  At approximately 22 weeks, T and B lymphocytes begin to 
segregate and by week 24, white pulp and surrounding marginal zone framework is 
established (Satoh et al., 2009).  In rats, small numbers of immature B and T 
lymphocytes are not observed until birth with formation of the marginal zone framework 
occurring approximately a week postpartum.  Germinal centers, sites of B cell 
proliferation and development, are not present until the time of weaning (Holsapple et 
al., 2003).   
Once mature, B and T lymphocytes express specific membranous proteins often 
used for localization and quantification of respective lymphocytes in histological and 
protein analyses.  Specifically, B lymphocytes express CD20 on the membrane and T 
lymphocytes similarly express CD3 on the membrane of both cytotoxic and helper T 
cells, which aid in scientific determination of adaptive immune cell makeup of the 




erythrocytes are often determined in immunohistological staining through an iron-
specific stain, which stains the oxygen-carrying hemoglobin.     
 Of particular importance to the equine athlete, the mature spleen acts as a 
reservoir for erythrocytes and filters/replaces old and damaged erythrocytes.  Blood from 
circulation enters the spleen through a series of “cords” and sinuses which are lined with 
unique endothelial cells and stress fibers (Drenckhahn and Wagner, 1986).  When it 
becomes difficult for erythrocytes to pass through the sinuses due to aging and stiffening 
of membranes, they are phagocytized by residing macrophages (Mebius and Kraal, 
2005).  Following erythrophagocytosis, macrophages of the spleen are able to recycle 
the iron present in hemoglobin of phagocytized erythrocytes and store or release as 
ferritin (Knutson and Wessling-Resnick, 2003).  If released, the ferritin can readily bind 
to transferrin, an important transporter protein (Knutson and Wessling-Resnick, 2003).  
Furthermore, the macrophages can use released iron to determine invasion by certain 
bacteria with a high affinity for iron (Ratledge and Dover, 2000) 
 In the horse, the spleen is able to contract during maximal exercise, releasing its 
erythrocyte stores into circulation, increasing hematocrit and oxygen carrying capacity in 
an effort to delay the onset of fatigue (McKeever et al., 1993).  Splenic contraction is 
induced by an increase in epinephrine in response to exercise and can increase 
erythrocyte volume by up to 50% (Kurosawa et al., 1998).  The spleen in the horse is 
able to store more erythrocytes than in other species because increased contraction of 




reduce stress on the heart by reducing viscosity through reduced PCV (Mebius and 
Kraal, 2005).   
 Related to immune function, the spleen plays a role in both innate and adaptive 
responses.  The white pulp plays a role only in adaptive immune responses; however, the 
marginal zone is able to mount both an innate and adaptive response because of the 
presence of both macrophage and B-cell populations (Mebius and Kraal, 2005).  
Macrophages of the marginal zone and the presence of blood-borne pathogens activate 
B-cells in the marginal zone to initiate an adaptive immune response.  The activated B-
cells then act as antigen-presenting cells, migrating to the white pulp and activating 
helper T-cells (Attanavanich and Kearney, 2004).  Upon activation of T-cells, they 
migrate to the edge of the B-cell follicles and are able to exit the spleen via lymphatic 
vessels to mount an immune response against blood-borne pathogens (Mebius and Kraal, 
2005).   
Insulin Resistance and Metabolic Disease 
 Adult-onset metabolic disease is becoming increasingly more common with the 
incidence of obesity rising.  Further, the increase in adult obesity is mirrored by an 
increase in childhood obesity and an earlier onset of adult metabolic diseases.  Often this 
is related to glucose homeostasis and insulin sensitivity; therefore, the tissues most 
affected are the pancreas and insulin-sensitive tissues, including skeletal muscle.  
Metabolic disease is characterized by increased adiposity, obesity, insulin resistance, 
high blood pressure, and cardiac diseases.  Below will detail the influence of insulin 





 Stimulation of the pancreas to release insulin from islet b-cells is imperative for 
normal glucose regulation.  Metabolic dysregulation in the form of insulin resistance or 
type 2 diabetes mellitus has a significant impact on the pancreas, resulting in 
hyperinsulinemia followed by b-cell dysfunction.  The function of b-cells is closely 
associated with the physiology and metabolism of insulin-sensitive tissues and are 
heavily regulated by glucose concentrations in circulation (Cerf, 2013b).  Insulin 
resistance occurs prior to the onset of type 2 diabetes in humans, mice, and livestock 
species.  While horses rarely enter into a state of diabetes, insulin resistance is 
commonplace and occurs in conjunction with obesity or other metabolic diseases, 
including equine metabolic syndrome and pituitary pars intermedia dysfunction (Johnson 
et al., 2012).   
 The first measurable indication of metabolic dysregulation is hyperinsulinemia at 
either a basal state or through glucose challenge.  When glucose uptake by insulin-
sensitive tissues is compromised by obesity, inflammation, or insulin resistance, the 
pancreas attempts to compensate for the diminished response to insulin by stimulating b-
cell replication (Figure I.6; Cerf, 2013b).  The increase in b-cell size and number is 
described as b-cell compensation and results in increased insulin secretion in response to 
hyperglycemia or post-prandial incretin-stimulation (Tarabra et al., 2012).  When b-cell 
compensation cannot be sustained to address chronic hyperglycemia, b-cell dysfunction 






Figure I.6 β-cell compensation in insulin resistant state (El-Kafrawy et al., 2014). 
 
 
 If hyperinsulinemia, described in humans as pre-diabetes, is not appropriately 
addressed through diet modifications and exercise, apoptosis takes over the ability of b-
cells to replicate and compensate, resulting in b-cell loss.  Once the population of b-cells 
declines beyond a point of normal insulin secretion, the patient is diagnosed with type 2 
diabetes mellitus (Figure I.7; Rhodes, 2005; Weir and Bonner-Weir, 2004).  In early 
stages of the disease, reversal is possible; however, if not addressed and the disease is 
allowed to progress, amyloid plaques begin to deposit in pancreatic islets and result in 
irreversible damage to the pancreas (Weir and Bonner-Weir, 2004).  In humans, this 
occurs approximately 10 years after initial diabetes diagnosis and insulin or incretin 







Figure I.7 Postnatal pancreatic b-cell growth in normal, non-diabetic obese, and type 2 
diabetic humans (Rhodes, 2005). 
 
 
As is common with most metabolic diseases, insulin resistance and type 2 
diabetes mellitus are multifactorial; therefore, hyperglycemia is not the only culprit in 
disease progression.  Obesity is also associated with increased inflammation and 
oxidative stress, which play an additional role in pancreatic b-cell damage and peripheral 
tissue insulin insensitivity.  Chronic hyperglycemia and obesity-associated inflammation 
increase formation of reactive oxygen species resulting in oxidative damage to 
mitochondria, endoplasmic reticulum, and DNA (Yuzefovych et al., 2013).   
Cytokines and adipokines present during the inflammatory response and through 




damage through oxidative stress and stimulation of apoptosis.  These cytokines include 
tumor necrosis factor a (TNFa), interferons, interleukins, and prostaglandins.  The exact 
mechanism by which inflammatory cytokines influence pancreatic b-cells is unclear.  
More extensive research has been performed in insulin-sensitive tissues instead of 
insulin secreting cells.  These data are described further in the following section.  It has 
been suggested that the influence of inflammatory cytokines on insulin release and b-cell 
health is primarily related to oxidative stress and infiltration of macrophages and other 
immune cells (Esser et al., 2014).  It is believed that the primary cytokine resulting in 
changes to b-cell metabolism is interleukin-1b (IL-1b; Maedler et al., 2002).  Increase in 
IL-1b presence in pancreatic islets stimulates recruitment of macrophages and other 
immune cells leading to cellular damage and apoptosis (Esser et al., 2014).  These 
effects stimulate a change in cell metabolism resulting in b-cell compensation and 
subsequent b-cell decline.   
 Insulin resistance in the horse is similarly characterized by hyperinsulinemia and 
regional adiposity.  While equine diets are naturally low in fat, diets high in non-
structural carbohydrates are common.  Excess carbohydrate intake alone can result in 
reduced insulin sensitivity; however, the conversion of excess carbohydrate to fat via de 
novo lipogenesis exacerbates the effects of carbohydrates resulting in obesity and related 
inflammatory effects on insulin sensitivity (Frank et al., 2010).    
 The similarity in insulin resistance and type 2 diabetes mellitus between horses 
and humans is striking.  Horses exhibit hyperinsulinemia, hyperglycemia, 




2010).  Horses also express a predisposition to laminitis, which may be performance-
ending for many horses.  While type 2 diabetes mellitus is rare in horses, insulin 
resistance is common and occurs through similar mechanisms described in humans and 
murine models.   For example, obesity has been associated with an increase in 
circulating cytokines, increased postprandial insulin secretion, sustained hyperglycemia, 
and increased leptin concentrations (Carter et al., 2009; Frank et al., 2010; Vick et al., 
2007).  In horses diagnosed with equine metabolic syndrome, an acute inflammatory 
insult resulted in sustained insulin release and dysregulation of glucose homeostasis, 
ultimately confirming insulin resistance and a state of b-cell compensation common in 
insulin resistance and pre-diabetes in humans and murine models (Tadros et al., 2013).   
 With glucose and insulin dysregulation documented at the pancreatic level, it is 
important to then investigate the changes in insulin-target tissues.  Skeletal muscle is the 
primary site of insulin-stimulated glucose uptake, and even slight adjustments in glucose 
uptake will have significant influence on whole-body glucose homeostasis, energy 
utilization, and animal performance.  Often, horses’ performance careers will span 
across 20 years; therefore, maintenance of glucose homeostasis is important for 
longevity.   
Skeletal Muscle 
 The sensitivity of skeletal muscle to insulin signaling for glucose uptake is 
imperative for glucose homeostasis and the maintenance of normal metabolism.  In the 
case of metabolic disease or insulin resistance, skeletal muscle becomes less sensitive to 




concentrations of insulin associated with b-cell compensation.  Hyperinsulinemia does 
not result in fewer insulin receptors or affinity of insulin receptor, as may be expected.  
Instead, resistance occurs within intracellular signaling pathways ultimately leading to 
reduced translocation of GLUT4 (Cho et al. 2001; Deshmukh, 2015; Guo et al., 2014; 
Hirosumi et al., 2002).   
 The most obvious of the pathways to be influenced is the AKT signaling pathway 
because of its direct relation to translocation of GLUT4 to an active membranous 
transporter.  Knockout models suggest that mice lacking AKT are more likely to develop 
type 2 diabetes compared to wild type (Cho et al., 2001).  Similarly, studies in human 
patients have determined reduced AKT signaling in skeletal muscle results in the 
reduced translocation of GLUT4 and sustained levels of hyperglycemia in individuals 
with type 2 diabetes (Karlsson et al., 2005).  Surprisingly, this pathway is not the only 
pathway impacted in insulin resistance or metabolic disease.   
Currently, one of the most heavily influenced pathways is the JNK pathway 
because of its association with obesity and inflammation.  Specifically, excessive 
adiposity increases the release of FFAs and inflammatory cytokines including TNFa, 
which decrease intracellular signaling of insulin to stimulate glucose uptake (Figure I.8 
;DeFronzo et al., 2015).  When TNFa binds to its TNF receptor and FFAs bind to toll-
like receptor 4 (TLR4) on skeletal muscle membrane, there is a resulting increase in 
phosphorylation of JNK resulting in downstream inhibition of insulin signaling of the 
PI3K-AKT pathway via serine phosphorylation of insulin receptor substrate 1(IRS-1).  




regulating the PI3K-AKT pathway and reducing GLUT4 translocation (DeFronzo et al., 
2015; Hirosumi et al., 2002).  Furthermore, an increase in JNK phosphorylation results 
in increased activation of inflammatory pathways and cellular response to stress, which 
contribute to the secondary symptoms of metabolic disease and insulin resistance 





Figure I.8 Influence of adiposity on reduced insulin sensitivity in skeletal muscle 
(DeFronzo et al., 2015).   
 
 
Lastly, the cell proliferation pathway involving ERK signaling has similarly been 
implicated in insulin resistance and metabolic disorders via up-regulation of ERK 
phosphorylation (Jiao et al., 2013; Ozaki et al., 2016).  It is suggested that increased 




resistance by reducing the translocation of GLUT4 (Jiao et al., 2013).  Furthermore, 
elevated phosphorylation of ERK may result in dephosphorylation of forkhead box O1 
(FOXO1) causing increased gluconeogenesis when gluconeogenesis should be 
suppressed (Wu et al., 2010).  Because of the multi-factorial effects on various insulin-
signaling pathways, ERK has been investigated as a target for the development of 
treatments against insulin resistance and associated metabolic disorders (Ozaki et al., 
2016).  
Influence of Maternal Nutrition on Organ Development and Function 
 Many environmental factors influence offspring phenotype during critical 
periods of development.  The effects became apparent following the Dutch Hunger 
Winter of 1944-1945 when the German government placed sanctions on the 
Netherlands, leaving food scarce.  Years later, children born to mothers pregnant during 
the Dutch Hunger Winter had an increased incidence of diabetes, hypertension and 
cardiovascular disease (Veenendaal et al., 2013).  Environmental factors now known to 
contribute to offspring phenotype and epigenetic modifications include nutrition, air 
pollution, environmental toxins, and certain drug classes.  The prevalence of obesity in 
humans and domesticated animals makes maternal plane of nutrition and the influence of 
obesity on offspring an important field of study.   
In livestock, both under- and overnutrition during fetal development have been 
documented to negatively impact offspring development.  In periods of drought, 
undernutrition may be prevalent in some livestock species reared for human 




concentrate diets high in non-structural carbohydrates.  With the understanding that 
maternal plane of nutrition influences offspring phenotype and metabolism, subsequent 
understanding of mechanisms underlying fetal origins of adult disease are becoming 
well-documented more than ever before.  The field of equine science is just beginning to 
document these molecular and phenotypic changes in the horse.  Because of this, equine 
scientists must make inferences from other species to begin to answer questions specific 
to the horse.  The abundance of research has been performed using murine and ovine 
models.     
Pancreas 
 Both under- and over-nutrition during pregnancy have been implicated in 
offspring pancreatic development and function, predisposing offspring to adult-onset 
metabolic diseases, including insulin resistance.  In livestock species, under-nutrition has 
been most extensively studied; however, in murine species, overnutrition has been 
heavily investigated related to human nutrition and health.  Insufficiencies in maternal 
plane of nutrition, whether over- or undernutrition during gestation, alter maternal 
glucose and insulin dynamics suggesting dysfunction of pancreatic or insulin-sensitive 
tissues to respond to glucose or insulin, respectively.  A study performed in our lab by 
Winsco et al. (2011) overfed mares during the third trimester of gestation and observed 
reduced insulin sensitivity in mares 20 d prior to expected parturition in overfed mares 
compared to control.  In offspring, a similar reduction in insulin sensitivity was 




Similarly, a study in which mares were overfed from mid- to late gestation described a 
reduction in insulin sensitivity in foals by 19 mos. of age (Robles et al., 2017). 
The mechanism by which foals experienced reduced insulin sensitivity by 6 
months of age following exposure to high maternal plane of nutrition has yet to be 
determined in the horse; however, research in other species suggests the pancreas plays a 
prominent role.  The data from these studies are important for developing hypotheses 
and inferences for equine research. While the effect of over- and undernutrition on 
pancreatic development appear to oppose one another, insulin resistance and type 2 
diabetes mellitus are consistently the end result. 
 As previously described, overnutrition is more prevalent in the equine industry.  
Data from nutrient restriction models of developmental programming nevertheless 
provide valuable information.  The thrifty hypothesis developed by Dr. Barker suggests 
that fetal exposure to maternal undernutrition results in offspring prepared for a nutrient 
restricted environment; therefore, they are programmed to thrive with lesser nutrient 
availability (Figure I.9; Hales and Barker, 2001).  If these offspring are then exposed to 
sufficient or excess nutrients postpartum, the consequence is obesity and all associated 
metabolic disorders (Hales and Barker, 2001).  The influence of maternal undernutrition 
compared to overnutrition on the pancreas are opposite but interestingly, the end result 
of both circumstances is obesity, type 2 diabetes mellitus, cardiovascular disease, and 







Figure I.9 Influence of maternal undernutrition on the development of metabolic 
syndrome in offspring (Hales and Barker, 2001). 
 
 
Maternal undernutrition resulting in intrauterine growth restriction often results 
in reduced pancreatic mass and endocrine islet area (Petrik et al., 1999).  Offspring 
exposed to low-calorie diets in-utero consistently have fewer pancreatic islets with 
reduced b-cell mass (Boehmer et al., 2017; Garofano et al., 1998; Limesand et al., 2005).  
As would be expected, reduced b-cell mass results in reduced insulin secretion in 
offspring and type 2 diabetes mellitus (Limesand et al., 2006).  The cause of diminished 
b-cell mass is believed to be a defect in b-cell replication and altered expression of genes 
involved in apoptosis, proliferation, and neogenesis (Boehmer et al., 2017; Garofano et 
al., 1998; Limesand et al., 2005).  Offspring exposed to a low protein diet express 




attributed to a reduction in Pdx1 and IGF-II expression (Arantes et al., 2002; Petrik et 
al., 1999).  As previously described, PDX1 is the primary regulatory transcription factor 
in early pancreatic development to stimulate both endocrine and exocrine differentiation.  
Sensitivity to IGFs occurs later in gestation; therefore, the timing of maternal plane of 
nutrition modification affects the organ differently but may result in the same phenotypic 
expression.   
 Maternal overnutrition has been less extensively studied, and the mechanism 
predisposing offspring to adult metabolic disease is not as clearly outlined as that of 
maternal undernutrition.  There is some evidence using ovine and murine models, 
however.  Maternal obesity and overnutrition on the pancreas have revealed variable 
results.  Some studies have observed similar results to what is observed following 
maternal undernutrition: reduced pancreas size, reduced islet area, and reduced b-cell 
mass and number (Frantz et al., 2011; Zhang et al., 2011).   Other studies, however, have 
observed increases in islet area and subsequent increases in b-cell number and mass 
(Ackermann and Gannon, 2007; Ford et al., 2009).  The difference is likely related to 
timing and severity of exposure to maternal overnutrition. 
 In studies where maternal obesity and overnutrition resulted in similar results to 
maternal undernutrition, the obesity or overnutrition exposure was extreme and occurred 
early in gestation (Caton et al., 2009; Zhang et al., 2011).  Similarly, in these studies, the 
rate and length of overnutrition exposure was significant enough to induce intrauterine 
growth restriction, which explains the similarity in pancreatic effect to nutrient restricted 




overnutrition has resulted in increased b-cell mass, similar to what is observed during b-
cell compensation in early insulin resistance prior to diagnosis of type 2 diabetes 
mellitus (Ford et al., 2009).  These data suggest that length and severity of changes in 
maternal plane of nutrition stimulate pancreatic changes similar to the pathophysiology 
of insulin resistance and type II diabetes mellitus in mature animals.  Specifically, short-
term exposure to overnutrition whether in-utero or postpartum results in b-cell 
compensation while long-term exposure results in b-cell loss.   
 The consistent influence of maternal plane of nutrition on the pancreas 
demonstrates the potential for downstream impact on insulin-sensitive tissues.  With 
skeletal muscle being the primary tissue for insulin-stimulated glucose uptake, it will be 
important to investigate the potential effects on glucose and insulin metabolism with 
skeletal muscle as an important contributor.  As with the pancreas, skeletal muscle may 
be influenced by both under- and overnutrition of the dam.  
Skeletal Muscle 
 The effect of maternal plane of nutrition may influence either embryonic or fetal 
stages of myogenesis.  Embryonic influences of maternal nutrition primarily affect total 
skeletal muscle fiber number.  The number of skeletal muscle fibers present at birth is 
regulated by the number of available MPCs, which is susceptible to effects of maternal 
plane of nutrition during the embryonic phase of development (Nesvadbova and 
Borilova, 2018).  Following the embryonic phase of development, skeletal muscle fiber 
number is effectively fixed.  The influence of maternal plane of nutrition during the fetal 




type, adiposity, and collagen.  Although skeletal muscle fiber number may not be 
influenced when maternal plane of nutrition is altered during the fetal phase, these 
effects during secondary myogenesis may significantly influence the ability of skeletal 
muscle to adapt postnatally.  Furthermore, this may influence the ability of the horse to 
adapt to training and appropriately metabolize energy substrates for performance.   
 When maternal nutrition is restricted in the peri-implantation period, the result is 
reduced skeletal muscle density; however, when the nutritional insult is induced during 
late gestation the same effect is not observed, supporting the differentiation of skeletal 
muscle myoblasts during embryonic development (Costello et al., 2008).  In a similar 
study, rats were exposed to a low protein diet during early, mid, late or total gestation 
and authors observed a similar reduction in muscle fiber number and density of fast and 
glycolytic fibers of the soleus; however, the gastrocnemius muscle experienced a 
reduction in oxidative fibers (Mallinson et al., 2007).  
 Shifts in skeletal muscle fiber type may have a significant impact on muscle 
quality, performance, and metabolism.  Lower muscle fiber density has been associated 
with increased adiposity and collagen cross-linking when exposed to maternal 
overnutrition (Yan et al., 2010; Yan et al., 2011).  The combination of shift in skeletal 
muscle fiber types with an increase in adiposity and collagen cross-linking substantially 
influences skeletal muscle metabolism with the potential to predispose animals to 
metabolic disorders.  Skeletal muscle fiber type responds to maternal plane of nutrition 
in a manner in which the least essential fiber type appears to be sacrificed; although this 




 Changes in skeletal muscle fiber type influences skeletal muscle metabolism with 
slow twitch and fast-oxidative fibers operating primarily under aerobic conditions, while 
fast-glycolytic fibers continue metabolism under anaerobic conditions.  A shift towards 
oxidative fibers increases ability to utilize glucose and fat sources of energy in the 
presence of oxygen.  However, under periods of anaerobic metabolism, these fibers are 
unable to sufficiently operate and reach a level of fatigue more quickly.  Paired with 
changes in metabolism associated with increased adiposity, maternal overnutrition may 
inhibit the ability of skeletal muscle to perform optimally.   
Increased adiposity results in increased paracrine signaling within skeletal 
muscle.  Specifically, adipocytes increase the release of cytokines resulting in reduced 
intracellular insulin signaling, as previously described (Hirosumi et al., 2002).  
Furthermore, increased collagen cross-linking has been shown to limit the ability of 
skeletal muscle to adapt and utilize energy substrates sufficiently (Huang et al., 2012).  
As such, changes in maternal plane of nutrition during any period of gestation may have 
a significant impact in skeletal muscle adaptation to exercise and the ability of skeletal 
muscle to efficiently utilize energy and perform to an animal’s genetic potential.   
The influence of maternal overnutrition on energy substrate metabolism has been 
most extensively studied in murine and ovine models.  Consistently in both species, 
maternal overnutrition results in reduced insulin signaling and an increased risk of type 2 
diabetes, associated with changes in gene expression and second messenger proteins 
related to multiple intracellular insulin signaling pathways.  Related to the insulin 




expression and protein concentration in both sheep and rat offspring (Bayol et al., 2005; 
Yan et al., 2010).  The same study in rats observed a similar decrease in GLUT4 at 
weaning, which is symptomatic of insulin resistance (Bayol et al., 2005).   
Downstream insulin signaling is more broadly influenced by maternal plane of 
nutrition than the INSR or GLUT4 transporter.  As previously descried, the PI3K-AKT 
pathway is directly responsible for stimulating GLUT4 translocation.  Maternal 
overnutrition and/or obesity reduced phosphorylation of AKT in lambs, but not total 
AKT levels, suggesting lesser insulin stimulation of the PI3K-AKT pathway (Yan et al., 
2010).  A similar response was observed in male rat offspring from overfed dams on a 
high fat diet (Latouche et al., 2013).  Down-regulation of this pathway results in reduced 
GLUT4 translocation, independent of total GLUT4 available; therefore, glucose 
clearance from circulation is impaired predisposing offspring to metabolic diseases 
earlier in life (Waller et al., 2011).    
Inflammation associated with increased adiposity affects the JNK signaling 
pathway and is heavily influenced by maternal overnutrition.  Although maternal 
overnutrition does not influence offspring weight at birth in livestock species, 
researchers have found a shift in skeletal muscle development towards increased 
adiposity and reduced skeletal muscle mass (Ford et al., 2009; George et al., 2010; 
Winsco et al. 2011; Yan et al., 2010).  As previously stated, adipocytes and myocytes are 
derived from the same mesenchymal cell population; therefore, a shift in maternal plane 
of nutrition during early gestation has a significant impact on the differentiation of 




maternal plane of nutrition is altered in mid- to late gestation, the JNK pathway is still 
negatively influenced, suggesting further effects of maternal plane of nutrition following 
differentiation of mesenchymal stem cells to adipose or muscle cell fates (Bayol et al., 
2008; Yan et al., 2010; Zhu et al., 2010).   
In sheep, an increase in circulating lipids during mid-gestation resulted in 
increased phosphorylation of JNK and TLR4 in the placenta, thereby exposing the 
developing fetal lamb to excess inflammatory mediators (Zhu et al., 2010).  Similarly, 
when exposed to an obesogenic diet during late gestation, resulting offspring had an 
increase in JNK phosphorylation in semitendinosus skeletal muscle (Yan et al., 2010).  
As a result, lambs also exhibited reduced phosphorylation of AKT, higher circulating 
insulin levels, and evidence of reduced insulin sensitivity (Yan et al., 2010).  These 
results have also been observed in murine models exposed to a “junk food” or cafeteria 
diet during pregnancy and lactation (Bayol et al., 2008). 
Similar to the influence of JNK signaling pathway up-regulation, an increase in 
ERK activation has been observed consistently in offspring of mares on a high plane of 
nutrition in various periods of gestation.  Again, an up-regulation in ERK signaling is 
believed to decrease phosphorylation of AKT in a similar fashion to JNK, but also to 
stimulate gluconeogenesis in skeletal muscle and liver.  The influence of maternal plane 
of nutrition on skeletal muscle ERK signaling remains unclear; however, it is suggested 
that changes in maternal plane of nutrition result in increased MAPK signaling, which is 
an upstream protein signaling molecule of ERK (Gavete et al., 2005).  Furthermore, little 




signaling pathway in skeletal muscle; however, maternal obesity has been observed to 
activate the ERK signaling pathway in adipose, liver, and heart (Fernandez-Twinn et al., 
2012).  Because liver is also sensitive to insulin, up-regulation of ERK in hepatic tissue 
also results in reduced insulin sensitivity via a reduction in AKT phosphorylation, 
similar to observations in skeletal muscle of mature insulin resistant animals (Brozinick 
et al., 2003).   
Spleen 
 Little research has investigated the influence of maternal plane of nutrition on the 
spleen and its function in postnatal life.  Ultimately, the research in non-human 
vertebrate spleen function is unclear and limited resulting in confusion and conflicting 
results.  Related to maternal plane of nutrition, much of the data currently documented 
include only changes in mass (Caton et al., 2009; Vonnahme et al., 2013).  Consistently, 
in response to maternal undernutrition, the spleen is smaller compared to control-fed 
animals, suggesting potential for reduced function (Vonnahme et al., 2013).  However, 
following maternal overnutrition or obesity, fetal spleen is often heavier than those from 
control-fed animals (Caton et al., 2009; Vonnahme et al., 2013).  Whether maternal 
overnutrition was implemented during early, mid-, or late gestation, lambs consistently 
had larger splenic mass than lambs from control ewes (Caton et al., 2009).  These data 
suggest that fetal spleen is sensitive to maternal plane of nutrition, but the influence, if 
any, this may have on splenic function postnatal is unclear.   
With the importance of the spleen in immune function and exercise performance 




performance or health in adulthood.  As previously stated, the prevalence of overfeeding 
in the equine industry is high; therefore, if foals are born with larger spleens in response 
to high maternal plane of nutrition, it is reasonable to hypothesize that an increase in 
splenic weight will increase red blood cell storage capacity.  Improved RBC storage 
capacity has the potential to increase the volume of RBC dumped into circulation 
following splenic contraction in response to intense exercise, assuming normal 
stimulation of contraction.  In collegiate athletes, splenic mass is quite variable with 
males having larger spleens than females, but there is no evidence that spleen size 
influences success in performance as a collegiate athlete (Hosey et al., 2006).  
Unfortunately, the described study did not interpret potential function of spleen 
associated with size, they only interpreted spleen size in athletes using ultrasound 
techniques.  While there appeared to be no influence of spleen size on athletic ability, 
horses are unique in the ability to stimulate splenic contraction during high intensity 
exercise; therefore, size may play a larger role in the horse than in human athletes.  
Splenic volume and subsequent contraction are often determined by measuring PCV in 
exercising horses and may be a reliable measurement in future studies to determine the 
influence of spleen size on performance and oxygen carrying capacity (de Solis et al., 
2012).  
Related to immune function, a larger spleen may also increase the capacity for 
storage of white blood cells, suggesting the potential for improved immunocompetence 
of both the innate and adaptive immune systems.  The ability of the immune system to 




health.  If the immune response is insufficient to heal a trauma or combat an infection, 
the trauma will fail to heal, and an infectious agent has the opportunity to worsen.  
Conversely, if an immune response is in excess of what is necessary, it could lead to 
further tissue damage.  In avian species, the spleen has been more extensively studied 
relating spleen size to immunocompetence.   
It was first observed in starlings that larger spleens mount a larger cell-mediated 
immune response following immune challenge with phytohaemagglutinin (Ardia, 2005).  
Related to nutrition, a protein restriction in rats resulted in smaller spleens, fewer cell 
volume, and less gene activation (Kenney et al., 1968).  More specifically, authors 
observed a reduction in antibody-forming cells in spleens of rats exposed to a protein-
restricted diet (Kenney et al., 1968).  Interestingly, Moller and Erritzoe (2000) 
performed a study in which they compared the spleen mass of birds killed by cats 
compared to those killed by other means.  Authors found a decrease in spleen size of 
birds killed by predator suggesting predator selection for weakened immune systems 
(Moller and Erritzoe, 2000).   On the other hand, it is possible that an increase in splenic 
mass not extreme enough to qualify as splenomegaly may have no significant impact on 
spleen function.   
Implications in the Horse 
 Influence of maternal plane of nutrition on fetal origins of adult disease may have 
significant implications to the horse.  Research specific to equine species is in its infancy 
but may significantly impact equine performance related to energy metabolism, 




other livestock species suggests an increased risk of adult-onset metabolic disease, 
insulin resistance, cardiovascular disease, and hypertension.  Specific to the horse, early 
studies have proven the predisposition of foals to metabolic disorders (Robles et al., 
2017; Winsco et al., 2011).  The molecular mechanisms by which this predisposition 
occurs have yet to be elucidated.  The ability to determine molecular alterations to 
describe observed phenotypic changes will provide a starting point in optimizing 
nutrition and/or development of nutraceutical interventions.  
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CHAPTER II  
EFFECT OF MATERNAL OVERNUTRITION ON GLUCOSE AND INSULIN 
DYNAMICS, AND PANCREATIC DEVELOPMENT IN THE FOAL 
 
Introduction 
 A mounting body of scientific evidence has identified linkages between the 
uterine environment during pregnancy and postnatal growth and health of offspring 
(Coverdale et al., 2015).  With the prevalence of obesity and metabolic disorders in 
horses, investigation of the effects of maternal overnutrition is of critical importance for 
maximizing foal health.  While the negative effects have not been as extensively 
documented in the horse in comparison to other species, recent studies suggest maternal 
overnutrition during late gestation increases offspring risk for adult metabolic disorders 
including equine metabolic syndrome, insulin resistance (IR), obesity, and laminitis 
(Rossdale and Ousey, 2002; Stephenson et al., 2011).  A previous study performed by 
Winsco et al. (2011) determined that maternal overnutrition in late gestation decreases 
insulin sensitivity in mares 20 d prior to expected foaling date.  Resulting offspring were 
also found to have reduced insulin sensitivity, but this was not evident until 180 d of age 
(Winsco et al., 2011).   
 The molecular mechanism by which this predisposition to adult-onset metabolic 
disease occurs in foals has yet to be investigated.  Research in other species has observed 
differences in pancreatic size, b-cell size, and altered insulin production associated with 




maternal plane of nutrition (Dahri et al., 1995; Ford et al., 2009; Zhang et al., 2011).  
Kou et al. (2014) suggest that an increase in pancreatic islet number may be a major 
indicator of b-cell mass in humans.  Furthermore, an increase in b-cell mass has been 
associated with b-cell compensation related to insulin resistance and early diabetes in 
humans, mice, and livestock species (Cerf, 2013).  Therefore, the objectives of the 
present study were three-fold.  First, to determine the effects of maternal overnutrition 
during third trimester on maternal nutrient status and glucose regulation.  Second, 
determine the effects of maternal overnutrition on foaling parameters, foal physical 
measurements, and foal glucose regulation.  Third, to determine the effect of maternal 
overnutrition on pancreatic histoarchitecture and immunoreactive insulin, glucagon, and 
somatostatin.   
Materials and Methods 
 All procedures and handling of horses were approved by the Texas A&M 
University Institutional Animal Care and Use Committee.   
Horses and Dietary Treatments 
 Sixteen pregnant Quarter horse mares (initial BW 541 ± 17.3 kg; initial BCS 5.96 
± 0.91) were used in a completely randomized design.  Mares were bred to a single 
stallion to reduce genetic variability.  All mares were maintained on pasture at a body 
condition score (BCS) 6 using the 1 to 9 scale outlined by Henneke et al. (1983).  Prior 
to the onset of the study, mares were stratified by BW, BCS and expected foaling date, 
and randomly assigned to one of two dietary treatments.  All mares were allowed ad 




duration of the study.  Dietary treatments began on gestational d 235 and consisted of a 
control diet (CON; n = 8) where all nutrients were fed to meet dietary requirements 
during late gestation, and an overfed dietary treatment (HIGH; n = 8) where mares 
received an additional 40% above CON (Table II.1).  Mares on the CON diet received 
0.1% BW commercial forage balancer (Empower Topline Balance, Cargill Animal 
Nutrition, Elk River, MN).  Mares on the HIGH diet received the same as CON plus 
0.7% BW commercial mare and foal concentrate (SafeChoice Mare and Foal, Cargill 
Animal Nutrition, Elk River, MN).  Mares were fed twice daily, and adjustments to feed 
offered were made according to changes in BW every 14 d.   
 
Table II.1 Nutrient analysis of maternal dietary treatments beginning on d 235 gestation. 
  
Coastal 
bermudagrass hay Forage balancer1 
Mare and foal 
concentrate2 
DM, % 90.06 89.14 89.94 
CP, % 6.50 34.16 18.26 
ADF, % 36.46 7.63 16.84 
NDF, % 61.58 16.88 32.17 
DE, Mcal/lb 2.35 3.43 1.45 
Ca, % 0.29 3.46 1.45 
P, % 0.16 1.81 1.07 
K, % 1.09 1.82 1.48 
Na, % 0.02 0.50 0.49 
Cl, % 0.30 0.98 0.98 
1Nutrena Empower Topline Balance (Cargill Animal Nutrition, Elk River, MN) fed at 
0.1% BW daily (as-fed) to both CON and HIGH dietary treatments. 
2Nutrena SafeChoice Mare and Foal (Cargill Animal Nutrition, Elk River, MN) fed at 







Mare Performance and FSIGTT 
 Mare performance parameters (BW, BCS, and rump fat thickness (RFT)) were 
recorded and blood samples collected every 14 d via jugular venipuncture until 
parturition.  A final maternal blood sample was collected within 1 h postpartum.  Body 
weights were collected using a digital platform scale, and BCS was determined by 3 
individuals.  Rump fat measurements were obtained via ultrasound images (Aloka SSD-
500V, Aloka, Inc., Tokyo, Japan) on the left hip at a point 5 cm dorsal of halfway 
between the first coccygeal vertebrae and the ischium (Westervelt et al., 1976).   
 On gestational d 285 and 315, mares underwent a modified frequent sampling 
intravenous glucose tolerance test (FSIGTT) using methods previously described 
(Caumo et al., 2000; Hoffman et al., 2003).  On the day of FSIGTT, horses were fasted 
from concentrate for 7 h and BW was taken using a digital platform scale at 1200.  
Jugular intravenous (IV) catheters were placed between 1200 and 1300 after aseptic 
preparation and local analgesia of the overlying skin and secured in place with adhesive 
bandaging tape.  After catheter placement, horses were given 1 h of rest prior to starting 
the FSIGTT.  Horses were allowed ad libitum access to water and hay throughout the 
FSIGTT as complete fasting may affect insulin action in horses (Forhead and Dobson, 
1997).  Horses were housed in individual stalls for the duration of the FSIGTT.   
 A baseline plasma sample was harvested immediately prior to starting the 
FSIGTT, and a glucose bolus of 0.3 g/kg BW (dextrose solution 50%, Producers 
Cooperative, Bryan, TX) was administered IV (Hoffman et al., 2003).  Blood samples 




administration.  At 20 min after initial glucose bolus, an insulin bolus of 30 mU/kg BW 
porcine insulin zinc suspension (Vetsulin, Intervet Inc., Millsboro, DE; Hoffman et al., 
2003a) was administered to mares, and additional blood samples were harvested at 22, 
23, 24, 25, 27, 30, 35, 40, 50, 60, 70, 80, 90, 100, 120, 150, and 180 min after initial 
glucose injection.  Catheter patency was maintained by administering heparinized saline 
(0.9% sodium chloride containing 10 units of heparin per mL) after harvesting blood.  
Blood samples were harvested into evacuated tubes containing sodium heparin (158 
U.S.P. Unites, Becton-Dickinson, Franklin Lakes, NJ) and immediately placed on ice 
until centrifugation at 2,700 x g for 10 min at room temperature.  All samples were 
centrifuged within 15 minutes of harvesting.  Plasma was harvested, and samples were 
stored at -20°C for subsequent determination of glucose and insulin.   
Parturition and Foal Sample Collection 
 When parturition was imminent, mares were moved into 12 × 12 ft box stalls, 
were continuously monitored, and parturition was attended.  No mares exhibited signs of 
dystocia.  Immediately following parturition, foals were removed from sight, smell, and 
sound of the mare.  Once standing, foals were weighed on a platform scale, and physical 
measurements were recorded including length, wither height, hip height, and heart girth 
circumference. Within an hour of birth, a jugular IV catheter was placed using the 
technique previously described.  After a 1-h rest period, foals underwent the same 
FSIGTT as previously described; however, insulin dosages were adjusted to 10 mU/kg 




 Immediately following foal FSIGTT, foals were humanely euthanized with 
pentobarbitol (Beuthanasia-D, Merck & Co. Inc., Madison, NJ).  All organs were 
harvested and weighed using a digital scale.  Weights for paired organs including 
adrenals, ovaries, and testis represent the total weight of both.  Testicular weight 
includes the tunica dartos with the epididymis removed.  Right kidney volume was 
determined through water displacement.  Tissues were fixed using optimal cutting 
temperature compound (OCT; Tissue-Plus O.C.T. Compound, Fisher Healthcare™, 
Pittsburgh, PA), paraformaldehyde, or snap frozen for later analyses.   
Leptin, NEFA, Glucose and Insulin Analyses 
Maternal plasma samples collected on d 234 and 1 h postpartum along with foal 
plasma were analyzed for leptin using a commercial multi-species radioimmunoassay 
validated for the horse using dual parallelism (RIA; catalog no. XL-85K, EMD 
Millipore, Burlington, MA) and non-esterified fatty acid (NEFA) using a commercial 
enzymatic colorimetric assay (catalog no. C1057; Wako Chemicals, Richmond, VA).  
All FSIGTT samples were analyzed for glucose and insulin concentrations using a 
colorimetric assay and a commercial ELISA kit, respectively (Glucose Assay Kit STA-
680; Cell BioLabs, Inc., San Diego, CA; Equine Insulin ELISA, Mercodia, Inc., 
Uppsala, Sweden).   
Histological Analyses of Pancreas Morphology 
A hematoxylin and eosin stain (H&E) was used to determine general pancreatic 
histoarchitecture using methods previously described (Dunlap et al., 2008).  Number and 




for pancreatic a-amylase.  Briefly, 5-µm sections of paraffin embedded pancreas were 
mounted to glass slides.  Antigen retrieval was performed using boiling 0.01 M sodium 
citrate buffer (pH 6.0) for pancreatic a-amylase using a rabbit anti-a-amylase polyclonal 
antibody (catalog no. sc-46657; Santa Cruz Biotechnology, Inc., Dallas, TX) at 1:100 
concentration.  Purified nonrelevant rabbit IgG was used as a negative control.  
Immunoreactive protein was visualized using Vectastain ABC Kit (Catalog no. PK 6101 
for rabbit IgG; Vector Laboratories, Burlingame, CA) following manufacturer’s 
instructions and 3,3’-diaminobenzidine tetrahydrochloride (catalog no. D5637; Sigma-
Aldrich, St. Louis, MO) as the color substrate.  Sections were prepared without 
counterstaining and a coverslip was fixed using Permount mounting medium (SP15-500; 
Thermo Fisher Scientific, Waltham, MA). Digital images were captured using Nikon 
DS-Ri1 camera with NIS-Element AR 4.30.02 software.  As endocrine cells lack the 
presence of a-amylase, the absence of positive staining indicated endocrine cells of the 
islets of Langerhans.  Islet number was determined using the average of 10 images per 
animal unit in a 20× field of fixed area in Image J version 1.52a (U.S. National Institutes 
of Health, Bethesda, MD).  Islet size was determined by the average area of 10 
representative islets per animal unit in a 40× field using the trace tool in Image J.    
Quantitative Immunofluorescence  
 Immunofluorescent localization of immunoreactive insulin, glucagon, and 
somatostatin in pancreas sections were performed as previously described (Johnson et 
al., 2001).  Briefly, 8-µm cryosections of pancreas were placed on glass slides.  Sections 




and rinsed in 0.02 M PBS containing 0.3% Tween (PBS/Tween).  Sections were blocked 
with normal goat serum (1:10 dilution) for 1 h at room temperature.  Sections were 
rinsed in PBS/Tween and incubated with the primary antibody overnight at 4°C in a 
humidified chamber.  Primary antibodies include polyclonal goat anti-insulin (catalog 
no. sc-7389; Santa Cruz Biotechnology), rabbit polyclonal anti-glucagon (catalog no. 
ab92517; Abcam, Cambridge, MA), and rat polyclonal anti-somatostatin (catalog no. 
ab30788; Abcam) at 1:100, 1:1000, and 1:100, respectively.  Species appropriate 
nonrelevant IgG were used as negative controls.  Sections were probed with rabbit anti-
goat IgG Alexa 488, goat anti-rabbit IgG Alexa 594 and goat anti-rat IgG Alexa 488 
(Invitrogen, Thermo Fisher Scientific, Pittsburgh, PA) at 1:250 for 1 h at room temp in a 
humidified chamber, rinsed with PBS/Tween and overlaid with Prolong Gold Antifade 
(Life Technologies, Carlsbad, CA).  Slides were stored at room temp in the dark 
overnight, and microscopic analyses were performed the following day.  Digital 
fluorescence images were captured with a Nikon DS-Q1Mc camera using NIS-Elements 
AR 4.30.02 software.  Signal for insulin, glucagon, and somatostatin were quantified 
using Image J software and the standardized procedures previously described (Arques et 
al., 2012) 
Statistical Analysis 
 Area under the curve (AUC) for glucose and insulin concentrations were 
determined using trapezoidal summation with individual baseline sample used as the 
trapezoidal base.  All data were analyzed using PROC MIXED of SAS (SAS, Inc., 9.4, 




interaction.  Main effects for tissue-specific analyses included only treatment.  Foal sex 
was found to be not significant and was removed from the model.  A paired t-test was 
used to compare CON to HIGH at individual timepoints.  Means are reported as 
LSMeans ± SEM.  P-values less than or equal to 0.05 were considered statistically 
significant and less than or equal to 0.10 considered a trend towards significance.   
Results 
Maternal Physical Measurements and Plasma Analysis 
There were no notable refusals of dietary treatments, as all horses readily 
consumed their respective diets.  Maternal change in BW tended to be different between 
dietary treatments with mares in the overfed group gaining twice that of mares in the 
CON group during third trimester (P = 0.07; Table II.2).  Additionally, HIGH mares 
increased in BCS while mares in the CON group decreased BCS (P = 0.02).  There was 
no observed difference in change in RFT measured via ultrasonography (P = 0.45).  
There tended to be a treatment×day interaction (P = 0.10) in maternal plasma leptin 
concentrations where at the start of dietary treatments, there was no difference in 
maternal leptin; however, at the time of parturition, HIGH mares had twice the 
circulating concentrations of leptin (P = 0.02; Table II.3).  There were no differences in 
NEFA concentrations in maternal plasma prior to the start of dietary treatments or 
immediately postpartum (P > 0.10; Table II.3), however there was an effect of day (P < 







 There were no treatment×day interactions for maternal FSIGTT performed on d 
285 and 315 gestation (Table II.4).  There was an influence of time in maternal FSIGTT 
for peak glucose (P < 0.01), baseline insulin (P = 0.03), and insulin AUC before 
administration of insulin (P < 0.01) characterized by an increase over time, independent 
of dietary treatment.  Dietary treatment influenced peak glucose (P = 0.02) and insulin 
AUC before administration of insulin (P = 0.01) where HIGH mares had higher peak 
glucose and a larger endogenous release of insulin from maternal pancreas compared to 
CON.   
 
Table II.2 Effect of maternal overnutrition on changes in mare physical measurements. 
 Treatment
1  P-Values 
Item CON HIGH SEM Trt2 
Change in BW, kg 24.80 45.84 5.51 0.07 
Change in BCS -0.60 0.21 0.14 0.02 
Change in RFT3, cm -0.03 0.04 0.03 0.45 
1Treatments consisted of control (CON; n = 8) where mares received free choice access 
to coastal bermudagrass hay (Cynodon dactylon) and 0.1% BW daily as-fed Nutrena 
Empower Topline Balance (Cargill Animal Nutrition, Elk River, MN), and overfed 
(HIGH; n = 8) where mares received the same diet as CON plus 0.7% BW daily as-fed 
Nutrena SafeChoice Mare and Foal (Cargill Animal Nutrition, Elk River, MN). 
2Trt = effect of dietary treatment. 







Table II.3 Effect of maternal overnutrition on maternal plasma concentrations of leptin 





CON HIGH Trt2 Day Trt*Day 
Leptin, 
ng/mL 235 7.65a 7.56a 1.52 0.21 0.44 0.10 
 Post-Partum 6.43
a 10.92b     
NEFA, 
mmol/L 235 0.17a 0.22a 0.03 0.14 < 0.01 0.36 
  Post-Partum 0.10a 0.15a         
1Treatments consisted of control (CON; n = 8) where mares received free choice access 
to coastal bermudagrass hay (Cynodon dactylon) and 0.1% BW daily as-fed Nutrena 
Empower Topline Balance (Cargill Animal Nutrition, Elk River, MN), and overfed 
(HIGH; n = 8) where mares received the same diet as CON plus 0.7% BW daily as-fed 
Nutrena SafeChoice Mare and Foal (Cargill Animal Nutrition, Elk River, MN). 
2Trt = P-values of dietary treatment. 




Table II.4 Effect of maternal overnutrition on maternal glucose and insulin dynamics using a frequent sampling i.v. glucose 




      Treatment1   P-Value  
Item   Time CON HIGH SEM Trt2 Time Trt*Time 
Glucose Baseline, mg/dL 285 90.61 113.31 13.55 0.52 0.26 0.34 
  315 88.02 83.60     
 Peak, mg/dL 285 362.85 415.44 25.23 0.02 < 0.01 0.63 
  315 442.73 520.92     
 AUC Before Insulin
3 285 4,936.16 5,605.44 365.92 0.19 0.16 0.67 
  315 5,648.49 5,990.57     
 AUC After Insulin
4 285 20858.00 18764.00 1,444.39 0.71 0.13 0.31 
  315 17,018.00 17,994.00     
 AUC Total 285 25,794.00 24,370.00 1,614.72 0.97 0.31 0.42 
  315 22,666.00 23,985.00     
Insulin Baseline, ng/dL 285 0.04 0.06 0.01 0.25 0.03 0.69 
  315 0.07 0.08     
 Peak, ng/dL 285 23.92 23.64 5.35 0.89 0.46 0.85 
  315 18.85 20.63     
 AUC Before Insulin 285 3.35 7.05 0.95 0.01 < 0.01 0.47 
  315 6.71 8.98     
 AUC After Insulin 285 86.97 107.82 85.15 0.24 0.19 0.34 
  315 120.78 312.37     
 AUC Total 285 90.32 114.88 85.16 0.22 0.18 0.34 




Table II.4 Continued 
1Treatments consisted of control (CON; n = 8) where mares received free choice access to coastal bermudagrass hay (Cynodon 
dactylon) and 0.1% BW daily as-fed Nutrena Empower Topline Balance (Cargill Animal Nutrition, Elk River, MN), and 
overfed (HIGH; n = 8) where mares received the same diet as CON plus 0.7% BW daily as-fed Nutrena SafeChoice Mare and 
Foal (Cargill Animal Nutrition, Elk River, MN). 
2Trt = P-Values of dietary treatment. 
3AUC Before Insulin = area under the curve prior to intravenous dosage of insulin during FSIGTT. 




Foaling Parameters and Foal Physical Measurements 
 There were no differences in gestation length (P = 0.68), placental weight (P = 
0.73), or colostrum volume (P = 0.25; Table II.5).  Colostrum quality tended to be 
greater in CON mares compared to HIGH when measured using a refractometer (P = 
0.10).  Foal physical measurements including BW (CON 41.28 ± 1.69; HIGH 42.69 ± 
1.69), hip height (CON 64.06 ± 1.24; HIGH 95.25 ± 1.24), wither height (CON 92.71 ± 
1.35; HIGH 93.90 ± 1.35), length (CON 71.44 ± 1.23; HIGH 72.47 ± 1.23) and heart 
girth circumference (CON 77.23 ± 1.23; 78.11 ± 1.23) were not different between 
dietary treatments (P > 0.51).   
 
 
Table II.5 Effect of maternal overnutrition on gestation length, placenta weight and 
colostrum quality. 
  Treatment1   P-Value 
Item CON HIGH SEM Trt2 
Gestation Length, d 324.40 325.90 2.50 0.68 
Placenta Wt., kg 3.98 3.89 0.19 0.73 
Colostrum Volume, mL 679.40 991.90 182.90 0.25 
Colostrum Quality, Brix % 26.69 20.56 2.64 0.10 
1Treatments consisted of control (CON; n = 8) where mares received free choice access 
to coastal bermudagrass hay (Cynodon dactylon) and 0.1% BW daily as-fed Nutrena 
Empower Topline Balance (Cargill Animal Nutrition, Elk River, MN), and overfed 
(HIGH; n = 8) where mares received the same diet as CON plus 0.7% BW daily as-fed 
Nutrena SafeChoice Mare and Foal (Cargill Animal Nutrition, Elk River, MN). 







Foal FSIGTT and Pancreas Histology 
 There was no difference between dietary treatments for foal glucose or insulin 
baseline, peak, AUC before insulin, AUC after insulin or total AUC (P ³ 0.22; Table 
II.6).  Upon harvesting of organs post-euthanasia, there was no difference in pancreas 
weight (P = 0.64; Table II.7); however, the spleen (P = 0.04) and testis from male foals 
(n = 4/trt; P < 0.01), weighed more in foals from HIGH mares.  Similarly, foal cecum 
and empty large intestine weights also tended to be larger in foals from HIGH mares 
compared to CON (P = 0.06 and P = 0.08, respectively).   Pancreatic histoarchitecture 
(Figure II.1; Table II.8) indicated greater number of islets per area and larger islets of 
Langerhans in foals from HIGH mares compared to CON (P < 0.01).  Further analysis of 
immunoreactive insulin, somatostatin, and glucagon indicates no difference in intensity 
of staining of each hormone within the endocrine pancreas (P ³ 0.33; Figure II.2; Table 





Table II.6 Effect of maternal overnutrition foal glucose and insulin dynamics through a 
frequent sampling i.v. glucose tolerance (FSIGTT) test at 2 h postpartum. 
    Treatment1   P-Value 
Item   CON HIGH SEM Trt2 
Glucose Baseline, mg/dL 62.14 63.95 5.48 0.82 
 Peak, mg/dL 168.81 170.47 8.88 0.89 
 AUC Before Insulin3 2,259.95 2,353.51 114.31 0.59 
 AUC After Insulin4 9,665.50 9,464.41 1,212.67 0.91 
 AUC Total 11,467.00 11,788.00 1,422.95 0.88 
Insulin Baseline, ng/dL 0.025 0.027 0.006 0.85 
 Peak, ng/dL 4.06 6.14 1.16 0.22 
 AUC Before Insulin 2.59 1.82 0.62 0.38 
 AUC After Insulin 41.63 38.34 9.73 0.82 
  AUC Total 36.88 40.17 8.54 0.79 
1Treatments consisted of control (CON; n = 8) where mares received free choice access 
to coastal bermudagrass hay (Cynodon dactylon) and 0.1% BW daily as-fed Nutrena 
Empower Topline Balance (Cargill Animal Nutrition, Elk River, MN), and overfed 
(HIGH; n = 8) where mares received the same diet as CON plus 0.7% BW daily as-fed 
Nutrena SafeChoice Mare and Foal (Cargill Animal Nutrition, Elk River, MN). 
2Trt = P-Values of dietary treatment. 
3AUC Before Insulin = area under the curve prior to intravenous dosage of insulin 
during FSIGTT. 







Table II.7 Effect of maternal overnutrition on foal organ weights. 
1Treatments consisted of control (CON; n = 8) where mares received free choice access 
to coastal bermudagrass hay (Cynodon dactylon) and 0.1% BW daily as-fed Nutrena 
Empower Topline Balance (Cargill Animal Nutrition, Elk River, MN), and overfed 
(HIGH; n = 8) where mares received the same diet as CON plus 0.7% BW daily as-fed 
Nutrena SafeChoice Mare and Foal (Cargill Animal Nutrition, Elk River, MN). 
2Trt = P-Values of dietary treatment. 
3Kidney volume was determined using water displacement. 
4Ovary weight was collected on all female foals (HIGH n = 4; LOW n = 4). 
5Testis weight was collected on all male foals (HIGH n = 4; LOW n = 4). 
a,b superscripts indicate differences between dietary treatment (P < 0.05). 
 Treatment1  P-Value 
Item CON HIGH SEM Trt2 
Adrenals, g 5.52 6.23 0.38 0.21 
Brain, g 312.51 315.64 7.90 0.78 
Cerebellum, g 29.53 28.54 0.97 0.47 
Intestine, g 1416.80 1419.25 48.74 0.97 
Empty Small Intestine, g 621.00 560.57 28.85 0.17 
Full Cecum, g 46.03 50.68 2.74 0.23 
Empty Cecum, g 41.85 47.62 2.05 0.06 
Empty Large Intestine, g 244.92 273.46 10.88 0.08 
Heart, g 310.14 335.29 18.83 0.36 
Left Ventricle, g 107.91 110.99 6.18 0.73 
Right Ventricle, g 95.39 96.15 10.62 0.96 
Septum, g 94.66 92.83 7.19 0.86 
Left Kidney, g 96.01 94.68 4.62 0.84 
3Right Kidney Volume, mL 103.75 96.25 8.85 0.56 
Liver, g 740.75 736.00 48.36 0.95 
Longissimus Dorsi, g 373.50 372.86 17.51 0.97 
Lungs, g 542.75 614.00 34.12 0.16 
Omental Fat, g 95.16 86.70 6.57 0.36 
4Ovary, g 32.49 31.87 7.14 0.95 
Pancreas, g 16.67 18.21 2.29 0.64 
Spleen, g 162.25a 200.50b 11.99 0.04 
5Testis, g 20.50a 32.93b 1.93 < 0.01 




Table II.8 Effect of maternal overnutrition on foal pancreatic islets of Langerhans and 
endocrine hormones. 
  Treatment2   P-Value 
Item CON HIGH SEM Trt3 
Islet Number4 4.89 7.40 0.31 < 0.01 
Islet Size5 8.60 16.15 1.18 < 0.01 
Insulin 13.40 16.46 2.25 0.33 
Glucagon 11.80 9.92 2.00 0.51 
Somatostatin 9.74 11.77 2.33 0.53 
1Hormones expressed in arbitrary units as relative intensity of immunofluorescent 
staining. 
2Treatments consisted of control (CON; n = 8) where mares received free choice access 
to coastal bermudagrass hay (Cynodon dactylon) and 0.1% BW daily as-fed Nutrena 
Empower Topline Balance (Cargill Animal Nutrition, Elk River, MN), and overfed 
(HIGH; n = 8) where mares received the same diet as CON plus 0.7% BW daily as-fed 
Nutrena SafeChoice Mare and Foal (Cargill Animal Nutrition, Elk River, MN). 
3Trt = P-Values of dietary treatment. 
4Islet number was determined using the average ImageJ calculation on 10 images 
captured at 10x magnification. 
5Islet size, mm2 was determined using the average ImageJ calculation on 10 images 
captured at 10x magnification.  





Figure II.1 The effect of maternal overnutrition on foal pancreatic histoarchitecture via 
immunohistochemical staining for pancreatic a-amylase.  Islets of Langerhans are 
designated by the absence of positive staining.  Islets of Langerhans were more abundant 
(A; 10X) and larger (B; 20X) in foal pancreas from HIGH mares compared to CON.  Bar 










Figure II.2 The effect of maternal overnutrition on immunofluorescent staining of foal 
pancreas for insulin, glucagon and somatostatin. There was no difference in relative 
intensity of staining of immunoreactive insulin (A), glucagon (B) or somatostatin (C) 




 The present study examined the effect of maternal overnutrition on maternal 
nutrient status, glucose and insulin dynamics, foaling parameters, organ weights, and 
changes in pancreatic histoarchitecture and hormone production.  Previous research in 
our lab has shown changes in offspring glucose and insulin dynamics as early as 180 d 




al., 2011).  Other studies have observed similar metabolic changes in offspring of 
overfed horses; however, currently, no data exist to suggest the molecular mechanism or 
histological changes that explain this predisposition of foals to metabolic diseases 
(George et al., 2010; Robles et al., 2017).    
All mares maintained an acceptable BCS throughout all stages of gestation, both 
during and prior to the onset of dietary treatments.  Previous studies have observed a 
decrease in maternal BW during third trimester when using a hay only diet as the dietary 
control (Winsco et al., 2011); therefore, in order to avoid this potential state of nutrient 
restriction, we chose to supplement with the commercial forage balancer to ensure 
nutrient requirements were met that may otherwise be limited in a hay-only diet during 
the period of greatest fetal growth and development. The 24.8 kg gained by mares on the 
CON dietary treatment during third trimester agrees with expected fetal and placental 
growth during late pregnancy according to the NRC (2007).  Mares in the HIGH 
treatment group, however, gained 45.8 kg during third trimester, supporting the 
developed overnutrition model.     
 Determination of NEFA has been used previously to describe a state of nutrient 
restriction because an increase in circulating NEFAs indicates fatty acid oxidation for 
energy utilization when dietary energy supply is low (Tygesen et al., 2008).  There was 
no effect of dietary treatment on NEFA concentrations in mares indicating the CON diet 
was successful in meeting nutrient demands during late gestation.  The decrease over 
time, independent of dietary treatment, indicates that mares were mobilizing fewer fat 




both diet sufficiently met energy demands.  Furthermore, leptin, a hormone secreted by 
adipose tissue, is associated with a state of overfeeding and was used in this study to 
validate the HIGH dietary treatment (Fruhwurth et al., 2018).  Leptin was not different 
between dietary treatments at the onset of the study supporting all mares were similar 
prior to the start of dietary treatments.  By the end of dietary supplementation, however, 
HIGH mares had twice the circulating concentrations of leptin, suggesting an increase in 
adiposity in HIGH mares.  Furthermore, the increase in leptin in HIGH mares suggests 
an increase in abdominal fat not observed through the subcutaneous measurement of 
rump fat thickness via ultrasound in the present study. 
 Changes in maternal plane of nutrition during late gestation has previously been 
shown to alter glucose and insulin dynamics independent of gestational-related changes 
in glucose metabolism (George et al., 2011; Winsco et al., 2011).  The present study 
observed an increase in baseline insulin levels in HIGH mares at d 285 gestation along 
with an increase in insulin area under the curve prior to administration of an exogenous 
dose of insulin, indicating an increase in pancreatic response to glucose with no 
difference in peripheral tissue response to insulin.  These data suggest b-cell 
compensation in response to overfeeding as early as 50 d following the onset of 
overfeeding.  An increase in maternal pancreatic response may have a substantial impact 
on nutrient partitioning to the fetus, potentially causing the observed fetal pancreatic 
adaptations that result in adult onset of metabolic disease (Ford et al., 2009; George et 




 At d 315 gestation, agreeing with previous literature (George et al., 2011), mares 
exhibited increased peak glucose concentrations and insulin concentrations in an effort 
to shunt glucose toward the fetus for the final stages of development prior to parturition.  
George et al. (2011) describe this change in maternal glucose and insulin dynamics in 
the horse in detail.  HIGH mares had higher peak glucose concentrations, suggesting a 
potential delay in response to endogenously produced insulin in agreement with Winsco 
et al (2011).  These data from both FSIGTTs performed on mares in the present study 
during third trimester gestation suggest that natural changes, independent of dietary 
treatment, regulate nutrient supply to the developing fetus during peak fetal growth.  
Furthermore, maternal plane of nutrition during third trimester reduces insulin sensitivity 
and pancreatic response to circulating glucose.  
 Overfeeding during mid-late gestation has not affected offspring size or 
BW in most livestock species, including the horse, and the same was observed in the 
present study (Ford et al., 2009; George et al., 2010; Guay et al., 2002; Heidler et al., 
2004; Kubiak et al., 1988; Winsco et al., 2011).  Maternal overnutrition has, however, 
shown to alter the size of some organs, particularly using the sheep model (Ford et al., 
2009; George et al., 2010).  In the present study, empty cecum and large intestine weight 
in foals from HIGH mares tended to be larger.  This has not been previously documented 
in the horse; however, an increase in cecum and large intestine empty weight may 
increase fermentative capacity in foals from HIGH mares.  Total intestine weight, 





Furthermore, the testis of male foals from HIGH mares were larger compared to 
CON.  This has not been previously documented in the horse; however, a similar study 
performed by Robles et al. (2017) observed a delay in testicular maturation in response 
to maternal overnutrition in weaned horses up to two years of age, although no testicular 
weights were recorded.  The specific molecular culprit explaining the delay in testicular 
maturation has not been described; however, researchers suggest it could be hormonal 
related (leptin, insulin, and IGF1), or associated with the timing of testicular inguinal 
migration at approximately d 270 gestation in the horse (Robles et al., 2017).   
Lastly, the spleen was larger in foals from HIGH mares compared to CON which 
has been previously described in other species as the spleen is known to be sensitive to 
maternal plane of nutrition (Caton et al., 2009).  Little research has extended past the 
documentation of splenic size related to fetal programming; however, the spleen plays a 
specific role in the athletic horse and this increase in splenic size may indicate changes 
in splenic function.  During heavy exercise, the spleen contracts to release its stored 
RBC contents into circulation to increase oxygen carrying capacity and delay the onset 
of fatigue (McKeever et al., 1993).  An increase in splenic size may increase capacity for 
splenic dumping, improving athletic performance.  Furthermore, an increase in splenic 
size may improve immunocompetence and has been previously described in avian 
species (Moller and Erritzoe, 2000).  Further investigation into the effects of splenic size 
on function in the horse is necessary based on these data.    
Specifically related to glucose and insulin dynamics of interest in the present 




disagrees with studies performed in sheep where an increase in pancreas size was 
observed in offspring from obese ewes (Ford et al., 2009; George et al., 2010).  Species 
differences or the fact that HIGH mares never achieved a true state of obesity may 
explain the lack of difference in pancreas size in the present study. 
 Currently, no studies have observed changes in insulin sensitivity at birth.  The 
earliest observed changes to suggest reduced insulin sensitivity occurred at 160 and 180 
d postpartum by George et al. (2011) and Winsco et al. (2011), respectively.  A similar 
study performed using Saddlebred mares overfed from mid-late gestation, observed a 
reduction in insulin sensitivity in foals at 19 months of age (Robles et al., 2017).  In 
order for these metabolic disturbances to occur so early in life to predispose animals to 
adult-onset metabolic disease, there is likely a measurable molecular change at birth, 
programmed in-utero, to explain this susceptibility.   
 Other species have extensively studied molecular changes in the pancreas to 
explain metabolic diseases such as insulin resistance, diabetes, and metabolic syndrome 
(Butler et al., 2003; Dahri et al., 1995; Friedman, J. E., 2018; Limesand et al., 2007; 
Zhang et al., 2011).  However, this has not been determined in the horse where 
metabolic diseases are prevalent.  The endocrine pancreas is responsible for maintenance 
of blood glucose levels by responding to changes in blood glucose concentrations and 
releasing regulatory hormones including insulin and glucagon to maintain glucose 
homeostasis.  Changes in plane of nutrition or excessive inclusion of a single nutrient 
can have a negative impact on the ability of the pancreas to respond to fluctuations in 




mature, obese horses; however, prevalence has increased over time leading to the 
postulation of molecular variations in-utero (Johnson et al., 2012).   
 One of the earliest pancreatic molecular change to indicate reduced insulin 
sensitivity preceding insulin resistance is b-cell compensation, which is characterized by 
b-cells that are larger in size and number within the endocrine islets (Butler et al., 2003; 
Weir and Weir, 2004).  Displaying signs of b-cell compensation, foals from HIGH 
mares in the present study had more endocrine islets of Langerhans per area than mares 
on the CON diet.  In humans and mice, this has been observed in patients diagnosed with 
insulin resistance or pre-diabetes (Weir and Weir, 2004).  In a study performed using 
human pancreas from healthy adults with no history of pancreatitis or diabetes, 
investigators suggest that pancreatic islet number is correlated with an increase in b-cell 
mass.  It is accepted that an increase in b-cell mass is responsible for the increase in 
circulating insulin concentrations in humans and mice with insulin resistance and early 
diabetes (Butler et al., 2003; Cerf et al., 2013; Comstock et al., 2012; Weir and Weir, 
2004).  These data alone begin to describe the tissue-specific molecular changes in-utero 
that may explain the predisposition of offspring from overfed or obese mares to insulin-
related metabolic diseases.  Furthermore, larger islets of Langerhans were observed in 
foals from HIGH mares compared to CON.  Kou et al (2013), however, suggests a 
weaker correlation between islet size and endocrine cell mass. 
 Lastly, intensity of staining of immuonreactive pancreatic endocrine hormones 
showed no difference.  In animals exposed to maternal overnutrition, pancreatic islets 




(Dahri et al., 1995; Ford et al., 2009).  In the horse, change in maternal glucose and 
insulin dynamics has not shown to influence a-cell development or glucagon production 
at birth, which is in agreement with the present study (Fowden et al., 1999).  
Somatostatin, however, has not been extensively studied, particularly in the horse, in 
response to maternal plane of nutrition and this study indicates that maternal 
overnutrition during third trimester does not influence d-cell production of somatostatin.  
 In conclusion, maternal overnutrition during third trimester gestation altered 
maternal glucose and insulin dynamics 50 d following the onset of dietary treatments.  
As expected, there was no influence on foal physical measurements or glucose and 
insulin dynamics, agreeing with previous studies performed in the horse.  However, foals 
exposed to overnutrition during peak fetal growth exhibited an increase in size and 
number of islets of Langerhans suggesting b-cell compensation.  Although there was no 
difference in staining of immunoreactive insulin, glucagon and somatostatin, the changes 
in pancreatic histoarchitecture is the first tissue-specific measurement in the horse to 
explain the predisposition of offspring exposed to maternal overnutrition to adult-onset 
metabolic disease that was not previously observed until 180 d postpartum.   
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CHAPTER III  
EFFECT OF MATERNAL OVERNUTRITION ON FOAL SKELETAL MUSCLE 
DEVELOPMENT AND METABOLISM 
 
Introduction 
 The ability of skeletal muscle to meet its full genetic potential is imperative for 
performance horses.  Nonetheless, little research has been performed on fetal 
development of equine skeletal muscle.  As research in livestock species has progressed, 
it has becoming increasingly evident that maternal plane of nutrition plays a significant 
role in skeletal muscle development and subsequent metabolism which has the potential 
to limit skeletal muscle adaptation to training in the performance horse.  With the 
prevalence of obesity in the current equine population, the effect of maternal 
overnutrition is of critical importance. 
 Skeletal muscle fibers and adipose tissue are derived from the same 
mesenchymal cell population during fetal development (Yan et al., 2013).  
Abnormalities in maternal glucose and insulin resulting from overnutrition alters the 
differentiation of skeletal muscle leading to higher numbers of adipocytes and fewer 
skeletal muscle fibers at birth in pigs (Cerisuelo et al., 2009).  Although fewer skeletal 
muscle fibers were observed, greater skeletal muscle fiber diameter was recorded in 
offspring from overfed sows, which reduced the capacity of those skeletal muscle fibers 




 Related to skeletal muscle insulin signaling, obesity has been shown to reduce 
translocation of glucose transporter 4 (GLUT4) through a reduction in insulin sensitivity, 
related to changes in the insulin receptor (INSR) or activation of second messenger 
signaling molecules in the insulin signaling pathway (Hirosumi et al., 2002; Simar et al., 
2012).  We have previously described alterations in maternal glucose and insulin 
dynamics following maternal overnutrition in third trimester (Winsco et al., 2011).  
These modifications in maternal metabolism have proven to alter foal metabolism by 
180 d postpartum; however, the molecular mechanism by which this occurs is just 
beginning to be elucidated through analysis of the equine pancreas (Bradbery et al., 
unpublished; Winsco et al., 2011).  The objective of the present study was two-fold.  
First, determine the effect of maternal overnutrition on skeletal muscle fiber 
development.  Second, determine the effect of maternal overnutrition on skeletal muscle 
insulin signaling pathways related to adult-onset insulin resistance.    
Materials and Methods 
All procedures and handling of horses were approved by the Texas A&M 
University Institutional Animal Care and Use Committee.  
Horses, Dietary Treatments, and Mare Performance 
The nutritional model used in this study is described by Bradbery et al. 
(unpublished).  Briefly, 16 Quarter Horse mares were used in a completely randomized 
design.  All mares were allowed ad libitum access to coastal bermudagrass hay 
(Cynodon dactylon) and treatments consisted of a control diet (CON; n = 8), where all 




dietary treatment (HIGH; n = 8) where mares received an additional 40% above CON 
beginning on d 235 gestation.   
Parturition and Foal Sample Collection 
 Immediately following parturition, foals were removed from sight, smell and 
sound of the mare.  At 2 h postpartum, foals underwent a frequent sampling i.v. glucose 
tolerance tes (FSIGTT) as described by Bradbery et al. (unpublished).  At 5 h 
postpartum, foals were euthanized using pentobarbitol (Beuthanasia-D, Merck & Co. 
Inc., Madison, NJ) and tissues were harvested and either fixed using optimal cutting 
temperature compound (OCT; Tissue-Plus O.C.T. Compound, Fisher Healthcare™, 
Pittsburgh, PA) or snap frozen for subsequent analyses.   
Immunofluorescent Histological Analyses of Skeletal Muscle Fiber Type and GLUT4 
localization 
 Immunofluorescent localization of immunoreactive type I and type IIa skeletal 
muscle fiber types was performed using a modified method described by Tulloch et al 
(2011).  Briefly, 5-µm cryosections were fixed in cold methanol for 10 min at 20°C.  
Surrounding OCT was removed from each section and rinsed in phosphate-buffered 
saline (PBS).  Immediately after, goat polyclonal anti-collagen V antibody (1:10 
dilution; Southern Biotechnology, Birmingham, AL) was applied to each slide and 
incubated in a humidified chamber for 1 h at room temperature.  Slides were washed for 
5 min in PBS after which mouse monoclonal antibodies for detection of type I (slow 
myosin antibody, MAB1628, MilliporeSigma, Dermstadt, Germany) and type IIa (Type 




were individually labelled with Alexa fluor-conjugated IgG Fab fragments with emitting 
350 and 488 wavelengths, respectively (Zenon Alexafluor 350 mouse IgG labelling kit; 
Zenon Alexafluor 488 mouse IgG labelling kit, Invitrogen, Thermo Fisher Scientific, 
Pittsburgh, PA) for 1 h at room temperature in a humidified chamber.  Samples were 
then washed for 5 min in PBS followed by a 15 min incubation in 4% paraformaldehyde.  
Samples underwent a final wash for 5 min in PBS and were mounted using Prolong Gold 
Antifade (Life Technologies, Carlsbad, CA).  Slides were stored at room temp in the 
dark overnight, and microscopic analysis was performed the following day.  Digital 
fluorescence images were captured with Nikon DS-Q1Mc camera using NIS-Elements 
AR 4.30.02 software. Skeletal muscle fiber type was determined using Image J software 
version 1.52a (U.S. National Institutes of Health, Bethesda, MD).  Number of skeletal 
muscle fibers were determined using 10 images per sample in a fixed area.  Skeletal 
muscle fiber size was determined by the average area of 10 representative fibers per 
fiber type per animal unit in a 40x field.   
 Localization of immunoreactive GLUT4 was performed using methods 
previously described (Johnson et al., 2001).  Briefly, 6 µm cryosections of gluteus 
medius, semitendinosus, and triceps brachii were placed on glass slides and fixed with 
cold methanol for 10 min at 20°C.  OCT was removed from each section and rinsed in 
0.02 M PBS containing 0.3% Tween (PBS/Tween).  Sections were blocked with normal 
goat serum (1:10) for 1 h at room temperature.  Sections were rinsed in PBS/Tween and 
incubated with the primary antibody overnight at 4°C in a humidified chamber.  Primary 




MA) and mouse polyclonal rat anti-laminin (1:500; 11576, Abcam), respectively.  
Species appropriate nonrelevant IgG were used as negative controls.  Sections were 
probed with goat anti-mouse Alexa 488 (Invitrogen, Thermo Fisher Scientific, 
Pittsburgh, PA) at 1:250 for 1 h at room temperature in a humidified chamber, rinsed 
with PBS/Tween and overlaid with Prolong Gold Antifade with DAPI (Life 
Technologies, Carlsbad, CA).  Slides were stored at room temperature in the dark 
overnight, and microscopic analyses were performed the following day.  Digital 
fluorescence images were captured with a Nikon DS-Q1Mc camera using NIS-Elements 
AR 4.30.02 software.  
RNA Isolation and RT-qPCR Analysis 
Total cellular RNA was isolated from snap frozen gluteus medius, 
semitendinosus, and triceps brachii using TRIzol reagent according to manufacturer’s 
instructions (Thermo Fisher Scientific, Waltham, MA).  Quality and quantity of isolated 
RNA was determined using an Agilent Bioanalyzer (Agilent Technologies, Santa Clara, 
CA) and the NanoDrop 1000 (Thermo Fisher Scientific, Inc., Waltham, MA), 
respectively.  Synthesis of cDNA was performed as previously described from total 
cellular RNA using random primers (Invitrogen, Carlsbad, CA), oligo-dT primers, and 
SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, CA; Stewart et al., 2000). 
ABI PRISM 7700 with Power SYBR green PCR Master Mix as the detector was used to 
analyze mRNAs via qPCR according to manufacturer’s recommendations and using 
methods previously described (Satterfield et al., 2008).  Genes analyzed included Insulin 




Growth Factor 1 Receptor (IGF1R), Insulin-Like Growth Factor 2 Receptor (IGF2R), 
and Glucose Transporter 4 (GLUT4) with Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) used as the reference gene (Table III.1).  Primers used are described in Table 
1.  Data were analyzed using 7200HT SDS software (version 2.3, Applied Biosystems, 
Foster City, CA).  The relative quantification of gene expression was determined using 
the comparative CT method (Satterfield et al., 2008).   
 
Table III.1 Primers utilized for quantitative real-time PCR analyses of foal skeletal 
muscle. 





INSR-A GTTTTTGTCCCCAGACCGTC 73 XM_023644610.1 
 GACATCAGCAAGCGCCCT   
INSR-B TGGTGCCGAGGACACTAGA 96 XM_023644610.1 
 TTAGGGAAACCCGGAACCGT   
GLUT4 TTTGTGGCATTCTTTGAGATTGG 65 AF531753 
 CTGAAGAGCTCAGCCACG   
IGF1R TCCACCGAAGCGTCTTTCTC 88 XM_023651179.1 
 AGTGTGACCTTGCCACAACA   
IGF2R CCCGAGCTGTGCAGTTATACA 112 XM_023632974.1 
 CAGCACTTGATGACCCACAC   
GAPDH CAAGGCTGTGGGCAAGGT 59 NM_001163856.1 
  GGAAGGCCATGCCAGTGA   
 
 
Western Blot Analyses 
 Protein was extracted using 100 mg of snap frozen skeletal muscle.  Samples 
were homogenized in protein lysis buffer, centrifuged at max for 15 min at 4°C.  Protein 




Rad, Hercules, CA) with bovine serum albumin as the standard.  For western blot 
analyses, 50 µg protein was separated on 12% SDS-polyacrylamide gels and 
electrophorically transferred to nitrocellulose membranes.  Membranes were blocked 
using 5% nonfat dry milk in Tris-buffered-saline with 0.1% Tween (TBST) for 1 h at 
room temperature.  Polyclonal antibodies against phosphorylated and total c-Jun N-
terminal kinase (JNK; phosphorylated 1:250; total 1:1000; 9251, 9252, Cell Signaling 
Technologies, Danvers, MA), extracellular signal-regulated kinase (ERK; 
phosphorylated 1:1000; total 1:1000; 9101,9102, Cell Signaling Technologies), protein 
kinase B (AKT; phosphorylated 1:250; total 1:1000; 9271, 9272, Cell Signaling 
Technologies), glucose transporter 4 (GLUT4; 1:500; 33780, Abcam, Cambridge, 
United Kingdom), and insulin receptor b (IRb; 1:250; sc-81465, Santa Cruz 
Biotechnology, Dallas, TX) were incubated overnight in 2% milk-TBST at 4°C.  
Polyclonal glyceraldehyde-3-phosphate (GAPDH; 1:500; 2118, Cell Signaling 
Technologies) was used as a control protein for gluteus medius samples, and polyclonal 
tubulin (1:1000; 7291; abcam) was used as a control protein for semitendinosus and 
triceps brachii.  Membrane blots were washed for 30 min at room temperature with 
TBST followed by incubation with the appropriate peroxidase-conjugated secondary 
antibody for 1 h at room temperature and a final wash in TBST.  Proteins were detected 
using chemilluminescence (SuperSignal West Pico PLUS, Thermo Fisher Scientific, 
Waltham, MA) using manufacturer’s recommendations.  The amount of protein present 
was quantified by measuring the intensity of bands using a ChemiDoc EQ system and 





 All data were analyzed using PROC MIXED of SAS (SAS, Inc., 9.4, Cary, NC). 
Main effects tested were block and treatment.  Foal sex was found to be insignificant and 
was removed from the model.  Means are reported as LSMeans ± SEM.  P-values less 
than or equal to 0.05 were considered statistically significant and less than or equal to 
0.10 considered a trend towards significance.  
Results 
 The longissimus dorsi (LD) muscle was harvested at the time of euthanasia and 
used as a reference muscle to determine whole-body skeletal muscle mass.  As described 
by Bradbery et al. (unpublished), there was no difference in foal LD weight of the foal 
between maternal dietary treatments (P = 0.97).   
Skeletal Muscle Fiber Type and Size 
 In gluteus medius, semitendinosus, and triceps brachii muscles, there were 
greater numbers of type I skeletal muscle fibers (P £ 0.04) in HIGH foals compared to 
CON (Table III.2; Figure III.1).  Type IIx fibers were fewer in gluteus medius (P = 0.04) 
and tended to be fewer in semitendinosus (P = 0.09) in HIGH foals.  There was no 
difference in type IIa fiber number for gluteus medius or triceps brachii muscles (P ³ 
0.13), but there tended to be fewer type IIa fibers (P = 0.07) in semitendinosus of HIGH 
foals compared to CON.  All three skeletal muscles had a higher ratio of type I skeletal 






Table III.2 Effect of maternal overnutrition on skeletal muscle fiber number. 
    Treatment2   P-Value 
Muscle Item CON HIGH SEM Trt3 
Gluteus Medius Type I 3.46a 9.02b 0.96 < 0.01 
 Type IIa 33.03 28.82 1.83 0.13 
 Type IIx 36.96a 29.34b 2.32 0.04 
 TypeI:TypeII 0.05a 0.16b 0.02 < 0.01 
Semitendinosus Type I 1.33a 3.98b 0.48 < 0.01 
 Type IIa 28.01 20.46 2.80 0.07 
 Type IIx 32.33 26.21 2.52 0.09 
 TypeI:TypeII 0.02a 0.09b 0.01 < 0.01 
Triceps Brachii Type I 6.48a 10.53b 1.27 0.04 
 Type IIa 25.31 22.41 2.26 0.38 
 Type IIx 16.93 10.38 3.10 0.16 
  TypeI:TypeII 0.19a 0.33b 0.04 0.05 
1Number of skeletal muscle fibers per fixed area using 8 images per muscle per animal. 
2Dietary treatments are described by Bradbery et al. (unpublished). 
3Trt = P-Values of dietary treatment. 







Figure III.1 Immunofluorescent staining of immunoreactive skeletal muscle fiber type in 
gluteus medius (A), semitendinosus (B), and triceps brachii (C) muscles of foals from 
control (CON) or overfed (HIGH) mares.  Foals from HIGH mares had larger skeletal 
muscle fibers and an increase in type I slow twitch fibers (blue; I) compared to type II 
fast twitch fibers (IIa: green; IIx: Black).  Bar = 50 µm. 
 
 
 Related to skeletal muscle fiber size (Table III.3), type I fibers were larger in 
HIGH foals compared to CON for gluteus medius, semitendinosus, and triceps brachii 
(P £ 0.01).  Additionally, type IIa skeletal muscle fibers were larger in HIGH foals 
compared to CON for all skeletal muscle groups (P £ 0.04).  Finally, type IIx skeletal 
muscle fibers were larger in HIGH foals (P < 0.01) in gluteus medius, but there was no 
difference in type IIx skeletal muscle fiber size for semitendinosus or triceps brachii 




Table III.3 Effect of maternal overnutrition on skeletal muscle fiber area. 
    Treatment2   P-Value 
Muscle Fiber Type CON HIGH SEM Trt3 
Gluteus Medius Type I 7.75a 11.88b 1.30 0.01 
 Type IIa 8.99a 12.25b 0.58 < 0.01 
 Type IIx 13.68a 18.76b 0.88 < 0.01 
Semitendinosus Type I 7.02a 12.70b 0.84 < 0.01 
 Type IIa 11.16a 143.97b 0.72 0.02 
 Type IIx 20.60 22.20 2.20 0.61 
Triceps Brachii Type I 17.77a 26.20b 1.67 < 0.01 
 Type IIa 19.78a 26.41b 2.18 0.04 
  Type IIx 25.51 28.83 2.05 0.26 
1Fiber area give in mm2. 
2Dietary treatments are described by Bradbery et al. (unpublished) 
3Trt = P-Values of dietary treatment.  




 Relative expression of IGF1R mRNA (Figure III.2) was higher in triceps brachii 
of HIGH foals compared to CON (P < 0.01) but was not different by dietary treatment in 
gluteus medius or semitendinosus muscles (P ³ 0.19).  IGF2R mRNA expression tended 
to be lower in HIGH foals compared to CON (P = 0.08) but was not different between 













Figure III.2 Relative expression of IGF1R (A) and IGF2R (B) in gluteus medius, 
semitendinosus, and triceps brachii of foals from mares overfed during third trimester 




























































 Expression of INSR-A mRNA tended to be lower in triceps brachii of HIGH foals 
(P = 0.10), but was not different in gluteus medius or semitendinosus (P ³ 0.46; Figure 
III.3).  Finally, INSR-B mRNA expression was higher in triceps brachii of HIGH foals (P 
= 0.03) but was not different in gluteus medius or semitendinosus (P ³ 0.43).  In gluteus 
medius, GLUT4 mRNA expression was reduced in HIGH foals (P = 0.05) but was not 



















































Figure III.3 Relative expression of INSR-A (A), INSR-B (B), and GLUT4 (C) in gluteus 




































































Key Proteins in Insulin Signaling 
 There was no difference in protein quantities of IRb (Figure III.4) between diets 
in gluteus medius, semitendinosus, or triceps brachii.  However, in gluteus medius 
skeletal muscle samples, ratios of phosphorylated to total ERK1/2 and JNK were 
elevated in foals from HIGH mares compared to CON (P < 0.05; Figure III.5).  
Additionally, total ERK1/2 tended to be greater in CON mares compared to HIGH (P < 
0.10; Figure III.6).  There was no difference in phosphorylated or total protein levels of 
AKT irrespective of maternal diet or skeletal muscle type (P > 0.10; Figure III.5 and 
III.6, respectively).  There were also no differences in ERK1/2 or JNK in triceps brachii 
muscles (P > 0.10).  Lastly, there was no difference in GLUT4 protein levels between 















Figure III.4 Total protein concentration of IRb (A) and GLUT4 (B) presented as a ratio 
of total protein concentration/control protein in gluteus medius, semitendinosus, and 
triceps brachii of foals from mares overfed during third trimester gesatation.  Loading 
control proteins were tubulin (semitendinosus and triceps brachii) and GAPDH (gluteus 
medius).  There was no influence of treatment on loading control proteins.  Data are 
















Figure III.5 Protein concentration of phosphorylated ERK1/2 (A), JNK (B), and AKT 
(C) as a ratio of phosphorylated/total in gluteus medius, semitendinosus, and triceps 
brachii of foals from mares overfed during third trimester gestation. Data are presented 







































Figure III.6 Total protein concentration of ERK1/2 (A), JNK (B), and AKT (C) 
presented as a ratio of total protein concentration/control protein in gluteus medius, 
semitendinosus, and triceps brachii of foals from mares overfed during third trimester 
gesatation.  Loading control proteins were tubulin (semitendinosus and triceps brachii) 
and GAPDH (gluteus medius).  There was no influence of treatment on loading control 







 There was no observed difference in translocation of the GLUT4 transporter in 
gluteus medius, semitendinosus, or triceps brachii muscles across dietary treatments via 








Figure III.7 Immunofluorescent staining of immunoreactive GLUT4 (red) and laminin 
(green) showed no difference in translocation of GLUT4 from an intramembranous 
vesicle to an active membrane transporter in foals from CON (A) mares compared to 




 The present study examined the effect of maternal overnutrition on foal skeletal 
muscle fiber development and insulin signaling in an effort to determine the molecular 
mechanism by which foals from overfed mares are predisposed to metabolic disorders 
(George et al., 2010; Robles et al., 2017; Winsco et al., 2011).  Bradbery et al. 




study along with foaling parameters, foal physical measurements, and organ weights.  
The LD was used as a reference muscle to determine skeletal muscle mass, which was 
not different between dietary treatments.  The gluteus medius and semitendinosus 
muscles were selected based on their nature as hind limb muscles involved in propulsion 
whereas the triceps brachii was selected as a forelimb muscle playing an important role 
in elbow extension and the stay apparatus.  The present study found that maternal 
overnutrition during third trimester gestation results in larger skeletal muscle fibers by 
area and a shift toward type I skeletal muscle fiber type.  Furthermore, an increase in 
phosphorylation of ERK1/2 and JNK in gluteus medius suggests an increased activation 
of second messenger signaling, which begins to describe the molecular mechanism by 
which foals from overfed mares are predisposed to adult-onset metabolic disease.   
 In other species used for meat production, skeletal muscle fibers have been more 
extensively studied in response to maternal nutrition as it relates to consumer perception.  
In horses however, where animals are used for athletic performance, skeletal muscle 
fiber development is of critical importance to meeting genetic potential and may be 
significantly influenced by maternal plane of nutrition.  Most commonly, maternal 
undernutrition has been shown to consistently reduce skeletal muscle fiber diameter and 
cross-sectional area in ruminants (Du et al., 2010; Yan et al., 2013).  However, Cerisuelo 
et al. (2009) observed an increase in skeletal muscle fiber size in piglets following 
maternal overnutrition during secondary fiber development.  An increase in skeletal 
muscle fiber size has previously shown to inhibit the ability of skeletal muscle to adapt 




similar increase in skeletal muscle fiber cross-sectional area, which may influence 
skeletal muscle metabolism and limit the ability of fibers to adapt to early training in 
young horses. 
 A shift towards type I slow twitch skeletal muscle fibers has been observed in 
animals from overfed dams (Cerisuelo et al., 2009; Oliveira et al., 2018).  Type I slow 
twitch skeletal muscle fibers are slow to fatigue, but lack quick reactivity (Maltin, 2008).  
Conversely, type II skeletal muscle fibers are considered fast-twitch and react in quick 
bursts, but fatigue at a faster rate.  More specifically, type IIa fibers are oxidative with a 
high concentration of mitochondria for ATP production via the Krebs cycle and the 
electron transport chain (Maltin, 2008).  Type IIb fibers, however, are glycolytic with 
fewer mitochondria and rely heavily on glycolysis for ATP production.  While they are 
quick to fatigue, they are able to continue to perform under anaerobic conditions (Maltin, 
2008).  The reduction in type IIx fibers observed in HIGH foals in the present study may 
be associated with an increase in glucose transport to the fetus during development.  It is 
possible that an increase in fetal glucose and subsequent increase in fetal pancreatic 
response preferentially shifted skeletal muscle fiber development towards oxidative fiber 
types I and IIa (Boyle and Friedman, 2011).   
 Often, related to changes in tissue phenotype, there is a subsequent change in 
gene expression.  The genes of interest in the present study were those related to glucose 
and insulin signaling with a paired role in regulating skeletal muscle hypertrophy and 
hyperplasia, as previous research has indicated that maternal overnutrition predisposes 




This predisposition may occur at the level of the pancreas or a downstream tissue in 
glucose regulation.  With skeletal muscle as the primary tissue for insulin-stimulated 
glucose uptake where fetal insulin regulates fetal blood glucose by third trimester, any 
change in gene expression or intracellular insulin signaling will play a major role in the 
predisposition of offspring to adult-onset metabolic diseases.   
Expression of the tyrosine kinase receptors IGF1R and IGF2R when bound to 
their ligand are potent regulators of skeletal muscle hypertrophy and hyperplasia 
(Oksbjerg et al., 2004).  Because of their role in muscle growth and development, gene 
expression of these tyrosine kinase receptors is greatest in young, growing animals, and 
decreases with age (Oksbjerg et al., 2004).  In response to maternal plane of nutrition, a 
diet containing excess protein resulted in increased expression of IGF1R in pigs (Kalbe 
et al., 2017).  Offspring of cattle exposed to nutrient restriction during mid-gestation 
observed a reduction in IGF1R and IGF2R in skeletal muscle, indicating that IGF1R and 
IGF2R are nutrient sensitive and can have a significant impact on skeletal muscle growth 
and development in-utero (Paradis et al., 2017).  In the present study, IGF1R was greater 
in triceps brachii of foals exposed to overnutrition in-utero and IGF2R tended to be 
down-regulated in gluteus medius of foals exposed to maternal overnutrition.   
The increase in expression of IGF1R may explain the increase in cross-sectional 
area of skeletal muscle fiber in triceps brachii of HIGH foals.  There was no difference 
observed in expression of IGF1R in semitendinosus or gluteus medius; therefore, there 
are likely other factors regulating skeletal muscle fiber size other than expression of 




foals is in contrast to previous work which has observed an increase in IGF2R 
expression in offspring exposed to high fat diets and a decrease in expression in 
offspring exposed to nutrient restriction (Hyatt et al., 2007; King et al., 2013).  The lack 
of effect in gluteus medius and semitendinosus on IGF1R and semitendinosus and 
triceps brachii on IGF2R may be related to maternal overnutrition only during late 
gestation in the present study.  
Relative to glucose regulation, expression of the INSR-A tended to be lower in 
triceps brachii of HIGH foals but was not observed in gluteus medius or semitendinosus 
muscles.  Similarly, INSR-B was not different between dietary treatments in gluteus 
medius or semitendinosus, but HIGH foals had greater expression of INSR-B.  INSR-A is 
primarily responsible for insulin receptor transcription during fetal development while 
INSR-B controls insulin receptor protein transcription postnatally (Belfiore et al., 2017).  
An abundance of INSR-A in postnatal life has been associated with dysregulated cellular 
proliferation and insulin resistance associated with an increase in pancreatic b-cell 
hyperplasia (Belfiore et al., 2017).  Bradbery et al. (unpublished) observed an increase in 
size of islets of Langerhans in foals from overfed mares suggesting b-cell compensation; 
however, there was no difference in INSR-A expression in gluteus medius or 
semitendinosus, and triceps brachii tended to have lower expression of INSR-A 
suggesting the involvement of other factors.    
Expression of GLUT4 transporter mRNA expression was down-regulated in 
gluteus medius by maternal overnutrition which may greatly contribute to the 




GLUT4 mRNA expression was observed in offspring of rats fed a cafeteria diet (Bayol 
et al., 2005).  These data however, disagree with a previous study in adult, insulin-
resistant horse where GLUT4 mRNA expression and total protein concentration were not 
influenced by obesity or insulin resistance (Waller et al., 2011).  The authors instead 
observed translocation of GLUT4 from an intracellular vesicle to an active membrane 
transporter was negatively influenced leading to the investigation of second-messenger 
signaling proteins in the insulin signaling pathway (Waller et al., 2011).  The absence of 
influence on GLUT4 mRNA expression in the study performed by Waller et al. (2011) 
may be because the horses studied were adults with insulin resistance unrelated to 
maternal plane of nutrition.  The down-regulation of GLUT4 mRNA expression in 
gluteus medius of the present study suggests a potential for reduced GLUT4 protein 
levels and translocation after weaning when postprandial glucose regulation is enhanced.   
Total and phosphorylated concentrations of three intracellular signaling proteins 
were analyzed along with total protein concentrations of IRb and GLUT4.  Furthermore, 
the use of immunofluorescent staining was used to determine translocation of GLUT4.  
There was no observed difference in protein concentration of IRb or GLUT4 in the 
present study.  Bradbery et al. (unpublished) performed a FSIGTT on foals exposed to 
maternal overnutrition and recorded no difference in glucose regulation in response to 
the FSIGTT; therefore, it is no surprise that the present study observed no difference in 
IRb, GLUT4 protein concentration, or subsequent translocation using immunofluorescent 
techniques.  However, in gluteus medius, there was an increase in phosphorylation of 




consistently implicated in adult human patients with type 2 diabetes and in 
developmental programming studies (Du et al., 2009; Carlson et al., 2003; Hirosumi et 
al., 2002).   
Specifically, ERK1/2 is associated with the mitogen-activated protein kinase 
pathway and play a role in cell growth, proliferation, and survival (Guo, 2014).  A 
knockout model of ERK1 induced weight loss and improved insulin sensitivity; 
therefore, the increased activation of ERK1/2 in gluteus medius of neonates exposed to 
third trimester overnutrition supports an increased risk of obesity and a predisposition to 
reduced insulin sensitivity (Carlson et al., 2003; Guo, 2014).  Furthermore, increased 
expression of p-ERK1/2 may explain the increase in size of skeletal muscle fibers in the 
present study, which could further predispose offspring to abnormal muscle glucose 
metabolism and limitations to exercise adaptations.   
The JNK pathway is closely associated with inflammation and plays a role in 
obesity-associated insulin resistance caused by an increase in inflammatory cytokines 
(Hirosumi et al., 2002).  The increase in phosphorylation of JNK in gluteus medius of 
foals from HIGH mares in the present study suggests an increase in inflammatory 
cytokine signaling.  This increase in activation of the JNK pathway may shift 
development of skeletal muscle towards adipogenesis, downregulating myogenesis (Du 
et al., 2009).  Furthermore, increased phosphorylation of JNK at birth will predispose 
offspring to obesity-associated insulin resistance in adulthood, making the JNK pathway 
more sensitive to an increase in inflammatory cytokines associated with increased 




The increase in activation of downstream insulin signaling pathways, ERK and 
JNK, predisposing offspring to metabolic disorders suggests that any excess adiposity 
during adulthood may exacerbate the influence of adipose tissue macrophages, 
inflammatory cytokines and free fatty acids resulting in early-onset adult metabolic 
syndromes (Baskin et al., 2015).  Furthermore, the observed increase in type I:type II 
skeletal muscle fibers in the gluteus medius suggests that maternal overnutrition may 
drive the gluteus medius to a fiber type phenotype resembling that of a normal triceps 
brachii muscle with a potential preference for fatty acid energy substrates resulting in 
reduced glucose utilization during anaerobic exercise.   
Downstream insulin signaling was not influenced by dietary treatment in triceps 
brachii, which may be explained by the observed differences in gene expression 
previously described.  Down-regulation of IGF2R combined with the shift in expression 
from INSR-A to INSR-B may be compensating and protecting the skeletal muscle cells of 
the triceps brachii from insulin dysregulation.  As a forelimb muscle, the triceps brachii 
plays a vastly different role than the gluteus medius and semitendinosus of the hind limb 
which may explain why the differences in gene expression and lack thereof in protein 
concentration only occurred in the triceps brachii muscle.   
In conclusion, maternal overnutrition during third trimester gestation altered 
skeletal muscle fiber growth and differentiation, expression of genes involved in insulin 
signaling and glucose uptake, and second messenger signaling protein activation in 
pathways associated with insulin signaling.  Together these data begin to demonstrate 




diseases, including insulin resistance.  Furthermore, larger skeletal muscle fibers paired 
with a preferential shift in skeletal muscle development towards type I slow twitch fibers 
may limit the ability of the performance horse to appropriately adapt to training, 
particularly in disciplines where quick bursts of speed are required, thereby preventing 
the horse from reaching its genetic potential during performance years.   
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CHAPTER IV  




 Maternal overnutrition negatively impacts multiple physiological systems; 
however, research is just beginning to elucidate these effects in equine species.  Multiple 
species have documented the influence of maternal plane of nutrition on organ mass and 
consistently describe the sensitivity of splenic mass to maternal plane of nutrition.  
Exposure to maternal nutrient restriction results in reduced splenic mass whereas 
maternal overnutrition results in larger splenic mass in sheep and cattle (Caton et al., 
2009; Vonnahme et al., 2013).  We have previously observed a similar increase in 
splenic mass in response to the influence of maternal over nutrition on foal development 
(Bradbery et al., unpublished).  While it has been consistently documented that the 
spleen is sensitive to maternal plane of nutrition, no studies have investigated the 
influence this may have on the function of the spleen during the offspring’s postnatal 
life.   
The spleen serves two major functions, filtration and storage of red blood cells 
(RBC) and storage of multiple white blood cell (WBC) populations.  During the 
filtration process, aged and damaged blood cells are recognized by abnormal passage 
rate through interendothelial slits within the spleen (Salehyar and Zhu, 2017).  Resident 




Furthermore, the extensive population of WBCs allow the spleen to act as a large lymph 
organ, with the ability to induce an immune response in the event of infection (Mebius 
and Kraal, 2005).  The equine spleen has a unique ability to contract during exercise, 
releasing its storage of RBCs into circulation at a rate that can double RBCs in 
circulation (Tablin and Weiss, 1983).  The release of RBC stores during exercise 
increases oxygen carrying capacity (OCC) and packed cell volume to delay the onset of 
fatigue and encourage continued exercise performance.   
 The field of developmental programming has yet to describe the functional 
differences of the spleen in response to maternal plane of nutrition.  An affiliated study 
determined that maternal overnutrition in the mare results in larger spleens in neonatal 
foals (Bradbery et al., unpublished).  The effect of a larger spleen may have positive 
effects on athletic ability and may lead to differences in immunocompetence.  Therefore, 
the objective of the present study was to determine the influence of maternal plane of 
nutrition and increased splenic mass on parameters of spleen function.   
Materials and Methods 
 All procedures and handling of horses were approved by the Texas A&M 
University Institutional Animal Care and Use Committee.  
Horses, Dietary Treatments, and Mare Performance 
The nutritional model used in this study is described by Bradbery et al., 
(unpublished).  Briefly, 16 Quarter Horse mares bred to a single stallion to reduce 
genetic variability were used in a completely randomized design.  Mares were stratified 




two dietary treatments beginning on d 235 gestation.  All mares received ad libitum 
access to coastal bermudagrass hay (Cynodon dactylon) and treatments consisted of a 
control diet (CON; n = 8) where nutrients were fed to meet dietary requirements during 
late gestation, and an overfed dietary treatment (HIGH; n = 8) where mares received an 
additional 40% above CON.   
Parturition and Foal Sample Collection 
 Immediately following parturition, foals were removed from sight, smell and 
sound of the mare.  At 2 h postpartum, foals underwent a FSIGTT as described by 
Bradbery et al. (unpublished).  At 5 h postpartum, foals were euthanized using 
pentobarbitol (Beuthanasia-D, Merck and Co. Inc., Madison, NJ) and tissues were 
harvested for analysis and fixed using paraformaldehyde or snap frozen in liquid 
nitrogen for later analyses.   
Wright-Giemsa and Iron Stain 
 Spleen samples fixed in paraformaldehyde were embedded in paraffin using a 
commercial laboratory (Veterinary Pathobiology Histology Laboratory, Texas A&M 
University, College Station, TX).  Sections 5 µm in size were mounted to glass slides.  A 
Wright-Giemsa stain was performed on two serial splenic sections, and an iron-specific 
stain was performed on differing sections using a local, commercial laboratory 
(Veterinary Pathobiology Histology Laboratory, Texas A&M University).  Digital 
images were captured using Nikon DS-Ri1 camera with NIS-Element AR 4.30.02 
software.  Percent area positive staining in the average of 10 images section at 20× 




containing cells using Image J version 1.52a software (U.S. National Institutes of Health, 
Bethesda, MD) and methods previously described (Batchu and Ebong, 2016; Varghese 
et al., 2014).   
Immunohistochemical Analyses of CD3 and CD20 
 Immunohistochemical localization for splenic CD3 and CD20 were performed to 
determine localization of T- and B-lymphocytes, respectively.  Briefly, 5 µm sections of 
paraffin embedded spleen were mounted to glass slides.  Antigen retrieval was 
performed using boiling 0.01 M sodium citrate buffer (pH 6.0) for CD3 using a rabbit 
anti-CD3 polyclonal antibody (catalog no. ab5690; Abcam, Cambridge, MA) and CD20 
using rabbit anti-CD20 polyclonal antibody (catalog no. ab27093; Abcam, Cambridge, 
MA) at 1:100 and 1:300 concentration, respectively.  Purified nonrelevant rabbit IgG 
was used as a negative control.  Immunoreactive protein was visualized using Vectastain 
ABC Kit (Catalog No. PK 6101 for rabbit IgG; Vector Laboratories, Burlingame, CA) 
following manufacturer’s instructions and 3,3’-diaminobenzidine tetrahydrochloride 
(catalog no. D5637; Sigma-Aldrich, St. Louis, MO) as the color substrate.  Sections 
were prepared without counterstaining and a coverslip was fixed using Permount 
mounting medium (SP15-500; Thermo Fisher Scientific, Waltham, MA).  Digital images 
were captured using Nikon DS-Ri1 camera with NIS-Element AR 4.30.02 software.  
Percent area positive staining in the average of 10 images per animal unit at 10× 
magnification was used to determine presence of CD3 and CD20 positive cells using 
Image J version 1.52a (U.S. National Institures of Health, Bethesda, MD) and methods 





 All data were analyzed using PROC MIXED of SAS (SAS, Inc., 9.4, Cary, NC).  
Main effects tested were treatment, sex and treatment*sex interaction.  There was no 
influence of sex on dietary treatments; therefore, it was removed from the model.  Means 
are reported as LSMeans ± SEM.  P-values less than or equal to 0.05 were considered 
statistically significant and less than or equal to 0.10 considered a trend towards 
significance.  
Results and Discussion 
  There was no influence of sex or treatment by sex interaction on any parameter 
measured, including: RBC, WBC, iron, CD3 and CD20 (P ³ 0.13).  Splenic weight of 
foals used in the present study was influenced by treatment (P = 0.03); however, spleen 
weight was not influenced by sex (P = 0.49; Female: 187.75 ± 12.62; Male 175.00 ± 
12.62).  It has been consistently documented that splenic mass is dependent upon sex in 
humans and many other species (Chow et al., 2015; Corbin et al., 2008; DeLand, 1970).  
Results of a cohort study of 1,200 healthy humans in the US reveal large spleen length 
and volume in males compared to females (Chow et al., 2015).  In children, however, 
one study observed no difference based on sex (Megremis et al., 2004).   
With little research performed in the spleen, it is possible that splenic size is not 
influenced by sex until later in life.  Several papers equate the difference in spleen size in 
males to immunosuppressive effects of testosterone and a compensation of the spleen to 
meet immune demands (Folstad and Karter, 1992).  If this theory holds true, it may 




present study and children in the study performed by Megremis et al. (2004; Bradbery et 
al., unpublished).  Splenic mass related to sex may only become apparent post-puberty 
when testosterone levels increase in males.   
 While there was no influence of sex nor an associated interaction, maternal 
overnutrition significantly influenced percentage area of RBC, WBC, and the ratio of 
RBC to WBC (P < 0.01; Table IV.1; Figure IV.1).  Generally, the spleen is analyzed as 
red pulp vs white pulp; however, with the understanding that multiple white cells 
infiltrate the marginal zone for local immune protection, determination of percentage 
area occupied by RBC or WBC may be more reliable in determining cellular 
localization, immunocompetence, and RBC storage capacity.  The percentage area of 
RBC was higher in foals from HIGH compared to CON (P < 0.01; Table IV.1).  
Increased storage capacity may contribute to increased athletic ability from a 
cardiovascular standpoint.  The equine spleen contracts during heavy exercise to release 
stored RBC contents into circulation in an effort to increase oxygen carrying capacity, 
reduce the load on the cardiovascular system, and delay the onset of fatigue (McKeever 









Table IV.1 Effect of maternal overnutrition on percentage area of red blood cell (RBC), 
white blood cell (WBC), and iron in the spleen of neonatal foals. 
  Treatment1  P-Values 
Item CON HIGH SEM Trt2 
WBC 56.54 44.02 2.73 < 0.01 
RBC 43.61 55.98 2.77 < 0.01 
RBC:WBC 0.81 1.31 0.11 < 0.01 
Iron 0.40 0.69 0.09 0.10 
1Treatments consisted of control (CON; n = 8) where mares received free choice access 
to coastal bermudagrass hay (Cynodon dactylon) and 0.1% BW daily as-fed Nutrena 
Empower Topline Balance (Cargill Animal Nutrition, Elk River, MN), and overfed 
(HIGH; n = 8) where mares received the same diet as CON plus 0.7% BW daily as-fed 
Nutrena SafeChoice Mare and Foal (Cargill Animal Nutrition, Elk River, MN). 






Figure IV.1 Effect of maternal overnutrition on percentage area of RBC and WBC via 
Wright Geimsa stain (A; 20X; RBC = Blue; WBC = orange) and percentage area of iron 
via an iron-specific stain (B; 20X; blue stain) in foal spleen samples from HIGH mares 





Hemoglobin is a key protein component of RBCs and contains iron to enable 
oxygen binding for transport to peripheral tissues.  As would be expected, the increase in 
percentage area RBC resulted in HIGH foals tending to have more iron stores in spleen 
sections compared to CON (P = 0.10; Table IV.1; Figure IV.1).  This suggests that 
spleen from HIGH foals exhibit an increase in oxygen carrying capacity following 
splenic contraction during exercise compared to CON foals. 
 Related to the spleen’s role as a lymphatic organ, percentage area of WBC 
understandably was inversely related to percentage area occupied by RBCs.  
Specifically, foals from CON mares had greater percentage area WBC compared to 
HIGH (P < 0.01; Table IV.1; Figure IV.1).  In chickens, splenic size is related to 
immunocompetence with larger spleens believed to mount a larger immune response 
(Ardia, 2005).  Related to plane of nutrition, a protein restricted diet in mice resulted in 
reduced antibody-forming cells of the spleen suggesting a diminished immune response 
(Kenney et al., 1968).  In the present study, lesser percentage area of WBC in HIGH 
foals may indicate that although splenic size is greater, immunocompetence may not be.   
The spleen contains white blood cells of both the innate and adaptive immune 
subsystems (Lewis et al., 2019).  Cells of the innate system recognize infection and 
stimulate a cascade of events ultimately resulting in adaptive immune activation of 
antigen-specific T- and B-lymphocytes.  B- and T- cells are located in different zones of 
the spleen (Figure IV.2).  In the present study, there was no difference in percentage area 
of B- or T- lymphocytes between dietary treatments.  (P > 0.19; Table IV.2).  These data 




be no difference in antigen-specific immune response of foals exposed to high plane of 




Figure IV.2 Effect of maternal overnutrition on percentage area of B- and T-
lymphocytes via immunohistochemical staining for CD20 (A; 10X) and CD3 (B; 10X), 





Table IV.2 Effect of maternal overnutrition on percent area of B- and T- lymphocytes in 
the spleen of neonatal foals. 
  Treatment1   P-Values 
Item2 CON HIGH SEM Trt3 
CD3 12.55 14.75 1.17 0.20 
CD20 12.82 14.40 1.47 0.46 
 
1Treatments consisted of control (CON; n = 8) where mares received free choice access 
to coastal bermudagrass hay (Cynodon dactylon) and 0.1% BW daily as-fed Nutrena 
Empower Topline Balance (Cargill Animal Nutrition, Elk River, MN), and overfed 
(HIGH; n = 8) where mares received the same diet as CON plus 0.7% BW daily as-fed 
Nutrena SafeChoice Mare and Foal (Cargill Animal Nutrition, Elk River, MN). 
2CD3 = marker of T-lymphocytes; CD20 = marker of B-lymphocytes 




These data are the first to describe the effect of maternal overnutrition on foal 
splenic development.  Maternal overnutrition resulted in increased spleen weight and a 
shift in favor of RBC over WBC percentage area.  With no difference in B- or T-cell 
area suggesting no change in immunocompetence, maternal overnutrition may improve 
the capacity of splenic contraction during exercise to increase oxygen carrying capacity 
and delay the onset of fatigue.  These data are purely based on histological analyses and 
further research is necessary to define immunocompetence in the spleen of foals exposed 
to a high plane of nutrition in-utero.   
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CHAPTER V  
CONCLUSIONS AND IMPLICATIONS 
 
Previous research in horses suggests reduced insulin sensitivity in foals exposed 
to maternal overnutrition as early as 6 mo age (Winsco et al., 2011).  The purpose of the 
present study was to further determine the influence of maternal overnutrition on the 
predisposition of foals to insulin resistance and metabolic disease at the tissue-specific 
level.  The study investigated changes in tissue histoarchitecture, gene expression and 
activation of second messenger signaling pathways to describe specific molecular 
changes related to maternal overnutrition.  Data from the present studies are the first 
evidence of molecular changes in offspring of overfed mares to describe the 
predisposition to adult-onset metabolic diseases. 
 With the prevalence of obesity in the equine population, increased attention is 
being paid to metabolic disorders specifically related to glucose regulation and insulin 
sensitivity.  These data suggest a multifactorial molecular influence of maternal plane of 
nutrition as predisposing factors for abnormal glucose and insulin dynamics.  Changes to 
histoarchitecture, gene expression, and intracellular protein phosphorylation were 
observed in pancreas and skeletal muscle, the primary organs involved in insulin-
stimulated glucose uptake.  Specifically, increased number and size of pancreatic 
endocrine islets paired with down-regulation of GLUT4 in gluteus medius and up-
regulation of key insulin-signaling intermediates suggest altered and compensatory 




metabolic disease.  The altered histoarchitecture and molecular mechanisms harbor the 
potential to prevent optimal energy utilization in performance years, reducing 
performance ability and longevity of the equine athlete.  Failure to perform at a horse’s 
genetic potential with compromised longevity may result in significant economic losses 
for owners and trainers.   
 While spleen weight is known to be sensitive to maternal plane of nutrition, little 
research has investigated the influence this may have on splenic function related to RBC 
storage capacity or immunocompetence.  This study provides the first evidence of 
nutritional-associated changes in histoarchitecture and cellular localization that may 
influence splenic function in offspring.  The spleen is known to play a significant role 
during peak performance in the horse through a process of splenic contraction where 
RBC contents are released into circulation to increase oxygen carrying capacity.  The 
results of the present study indicate an increase in RBC storage as opposed to WBC 
storage, which may provide an increased capacity for exercise and delay of fatigue.  The 
opposite, however, is a potential down-regulation of immunocompetence.  There was no 
observed influence on percentage area occupied by T- and B-lymphocytes; therefore, the 
difference may be among the innate immune cells which are responsible for sounding an 
immediate alarm of a pathogen or injury and stimulate the immune cascade.  Any 
compromise in the innate immune response may limit the ability of the adaptive immune 
system to mount the appropriate attack, thereby reducing immune function.   
 In summary, the data collected in this first of its kind equine developmental 




have on offspring phenotype, potential performance/longevity, and predisposition to 
adult-onset disease.  Continued collection of data in this field will improve dietary 
recommendations for pregnant mares and provide potential management techniques in 
offspring to allow the animal to meet its genetic potential.  Furthermore, improvement in 
longevity and decreased incidence of metabolic diseases will improve the economic 
contribution of the athletic horse.   
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